Tablet's
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Fexofenadine & Montelukast Sodium Tablets | Each chewable tablet contains Fexofenadine Hydrochloride Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 120 10 | mg mg |
| Atorvastatin Tablets IP 10 mg | Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used | IP | 10 q.s | mg |
| Atorvastatin Tablets IP 20 mg | Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used | IP | 20 q.s | mg |
| Atorvastatin Tablets IP 40 mg | Each filmcoated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used | 40 q.s | mg | |
| Atorvastatin &Fenofibrate Tablets | Atorvastatin Calcium Eq. to Atorvastatin Fenofibrate Excipients Approved colour used | IP IP | 10 145 q.s | mg mg |
| Febuxostat Tablets 40 mg | Each film coated tablets contains Febuxostat Excipients Approved colour used | 40 q.s | mg | |
| Pantoprazole Sodium & Domperidone Tablets | Pantoprazole Sodium eq. to Pantoprazole Domperidone Each enteric coated tablets contains Excipients Approved colour used | IP IP | 20 10 q.s | mg mg |
| Ferrous Ascorbate, Folic Acid & Methylcobalamin Tablet | Each film coated tablet contains Ferrous ascorbate eq. to Elemental iron Folic acid Methylcobalamin Excipients Approved colour used | IP IP | 100 1.5 1500 q.s | mg mg mg |
| Ondansetron Tablets IP 4mg | Each uncoated orally disintegrating tablets contains Ondansetron hydrochloride Excipients Approved colour used | IP | 4 q.s | mg |
| Ondansetron Tablets IP 8 mg | Each uncoated orally disintegrating tablets contains Ondansetron hydrochloride Excipients Approved colour used | IP | 8 q.s | mg |
| Betahistine Dihydrochloride Tablets IP 8 mg | Each uncoated tablet contains: Betahistine Dihydrochloride excipients | IP | 8 q.s | mg |
| Acebrophylline, fexofenadine HCl & Montelukast Sodium Tablets | Each film coated tablet contains Acebrophylline Fexofenadine hydrochloride Montelukast sodium eq. to Montelukast Excipients Approved colour used | IP IP | 200 120 10 q.s | mg mg mg |
| Acebrophylline (SR) Tablets | Each film coated sustained release tablet contains Acebrophylline Excipients Approved colour used Each film coated tablet contains Aceclofenac Paracetamol | IP IP | 200 q.s 100 325 | mg mg mg |
| Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets | Trypsin Chymotrypsin (50000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin & chymotrypsin activity in a ratio of 6:1) excipients Approved colour used | BP | 50000 Q.S | A.U |
| Aceclofenac Tablets IP 100 mg | Each film coated tablet contains: Aceclofenac excipients Approved colour used | IP | Q.S | mg |
| Aceclofenac, Paracetamol and Chlorzoxazone tablets | Each film coated tablet contains: Aceclofenac Paracetamol Chlorzoxazone Approved colour used Excipients | IP IP USP | 100 325 500 Q.S | mg mg mg |
| Aceclofenac, Paracetamol and Thiocolchicoside tablets | Each film coated tablet contains: Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used | IP IP IP | 100 325 4 Q.S | mg mg mg |
| Alfacalcidol, Calcium Carbonate eq.to Elemental Calcium tablets | Each film coated tablet contains: Alfacalcidol Calcium carbonate eq.to Elemental Calcium (from organic source oyster shell) Excipients Colour Titanium dioxide IP | BP IP | 0.25 200 Q.S | mg mg |
| Baclofen Tablets IP 10 mg | Each uncoated Tablet contains : Baclofen Excipients | IP | 10 Q.S | mg |
| Cilnidipine Tablets IP 10 mg | Each film coated tablet contains Cilnidipine Excipients Approved colour used | IP | 10 Q.S | mg |
| Cilnidipine Tablets IP 20 mg | Each film coated tablet contains Cilnidipine Excipients Approved colour used | IP | 20 Q.S | mg |
| Cilnidipine Tablets IP 5 mg | Each film coated tablet contains: Cilnidipine Excipients Approved colour used | IP | 5 Q.S | mg |
| Citicoline Tablet IP 500 mg | Each uncoated tablet contains: Citicoline Sodium eq.to Citicoline Excipients | IP | 500 Q.S | mg |
| Citicoline and Piracetam Tablets | Each film coated tablet contains: Citicoline Sodium eq.to Citicoline Piracetam Excipients Approved colour used | IP IP | 500 800 Q.S | mg mg |
| Clarithromycin Tablets IP 250 mg | Each film coated tablet contains: Clarithromycin Excipients Approved colour used | IP | 250 Q.S | mg |
| Clarithromycin Tablets IP 500 mg | Each film coated tablet contains: Clarithromycin Excipients Approved colour used | IP | 500 Q.S | mg |
| Desloratadine & Montelukast Sodium Tablets | Each film coated tablet contains: Desloratadine Montelukast sodium eq. to Montelukast Excipients Approved colour used | IP | 5 10 Q.S | mg mg |
| Desloratadine Tablet | Each film coated tablet contains: Desloratadine Excipients Approved colour used | IP | 5 Q.S | mg |
| Doxofylline & Ambroxol hydrochloride Tablets | Each film coated tablet contains: Doxofylline Ambroxol hydrochloride Excipients Approved colour used | IP IP | 400 30 Q.S | mg mg |
| Doxofylline Tablets IP 400 mg | Each uncoated tablet contains: Doxofylline Excipients | IP | 400 Q.S | mg |
| Etodolac Tablets IP 400 mg | Each film coated tablet contains Etodolac Excipients Approved colour used | IP | 400 Q.S | mg |
| Faropenem Sodium Tablets 200 mg | Each film coated tablet contains Faropenem Sodium Eq. to Faropenem Excipients Approved colour used | 200 Q.S | mg | |
| Faropenem Sodium Tablets 300 mg | Each extended release tablet contains Faropenem Sodium Eq. to Faropenem Excipients Approved Colour Used | 300 Q.S | mg | |
| Fluconazole Tablets IP 150 mg | Each uncoated tablet contains Fluconazole Excipients | IP | 150 Q.S | mg |
| Gabapentin & Nortriptyline Tablets | Each film coated tablet contains Gabapentin Nortriptyline HCl Eq. to Nortriptyline Excipients Approved Colour Used | USP IP | 400 10 Q.S | mg mg |
| Hydroxychloroquine Sulphate Tablets IP 200 mg | Each film coated tablet contains Hydroxychloroquine Sulphate Excipients Colour : Titanium Dioxide | IP | 200 Q.S | mg |
| Levosulpiride Tablets | Each uncoated tablet contains Levosulpiride Excipients | 25 Q.S | mg | |
| Montelukast Sodium Tablets IP | Each filmcoated tablet contains Montelukast Sodium Eq. to Montelukast Excipients Colour : Titanium Dioxide IP | IP | 10 Q.S | mg |
| Paracetamol , Phenylephrine HCl , Caffeine & Diphenhydramine HCl Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Caffeine Anhydrous Diphenhydramine HCl Excipients Colour: Approved Colour used | IP IP IP IP | 500 5 30 25 Q.S | mg mg mg mg |
| Paroxetine (CR) Tablets 12.5 mg | Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Approved Colour used | B.P | 12.5 Q.S | mg |
| Paroxetine (CR) Tablets 25 mg | Each film coated control release tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Colour: Approved Colour used Excipients | B.p | 25 Q.S | mg |
| Pregabalin (SR) Tablets 75 mg | Each sustained release tablet contains Pregabalin Excipients Colour: Approved Colour used | IP | 75 Q.S | mg |
| Rifaximin Tablets 200 mg | Each film coated tablet contains Rifaximin Excipients Colour: Approved Colour used | BP | 200 Q.S | mg |
| Rifaximin Tablets 400 mg | Each film coated tablet contains Rifaximin Excipients Colour: Approved Colour used | BP | 400 Q.S | mg |
| Rosuvastatin & Fenofibrate Tablets | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Fenofibrate Excipients Colour: Approved Colour used | IP IP IP | 10 145 Q.S | mg mg |
| Rosuvastatin Tablets 20 mg | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour: Titanium Dioxide | IP IP | 20 Q.S | mg |
| Roxithromycin & Ambroxol Tablets | Each film coated tablet contains Roxithromycin Ambroxol HCl Excipients Colour: Approved Colour used | IP IP | 150 30 Q.S | mg mg |
| Roxithromycin Tablets IP 150 mg | Each film coated tablet contains Roxithromycin Excipients Colour: Titanium Dioxide | IP IP | 150 Q.S | mg |
| Telmisartan Tablets IP 40 mg | Each uncoated tablet contains : Telmisartan Excipients Colour: Approved Colour used | IP | 40 Q.S | mg |
| Telmisartan Tablets IP 80 mg | Each uncoated tablet contains : Telmisartan Excipients Colour: Approved Colour used | IP | 80 Q.S | mg |
| Telmisartan & Chlorthalidone Tablets | Each film coated tablet contains Telmisartan Chlorthalidone Excipients Approved Colour used in coating | IP IP | 40 12.5 Q.S | mg mg |
| Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Telmisartan Hydrochlorothiazide Excipients | IP IP | 40 12.5 Q.S | mg mg |
| Telmisartan & Cilnidipine Tablets | Each film coated tablet contains Telmisartan Cilnidipine Excipients Colour: Approved Colour used | IP | 40 10 Q..S | mg |
| Telmisartan & Amlodipine Tablets | Each uncoated tablet contains Telmisartan Amlodipine Besylate Eq. to Amlodipine Excipients | IP IP | 40 10 Q.S | mg mg |
| Teneligliptin Tablets | Each film coated tablet contains Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Excipients Approved Colour used in coating | 20 Q.S | mg | |
| Teneligliptin & Metformin HCl (SR) Tablets | Each film coated tablet contains Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin HCl ( as sustained Release) Metformin HCl ( as sustained Release) Approved Colour used | IP | 20 500 Q.S | mg mg |
| Vildagliptin Tablets | Each uncoated tablet contains Vildagliptin Excipients | 50 Q.S | mg | |
| Vildagliptin & Metformin HCl Tablets | Each film coated tablet contains Vildagliptin Metformin HCl Excipients Approved Colour used | IP | 50 500 Q.S | mg |
| Vildagliptin & Metformin HCl Tablets | Each film coated tablet contains Vildagliptin Metformin HCl Excipients Approved Colour used | IP | 50 1000 Q.S | mg mg |
| Thiocolchicoside & Etoricoxib Tablets | Each film coated tablet contains Thiocolchicoside Etoricoxib Excipients Colour :Approved Colour used | IP IP | 4 60 Q.S | mg mg |
| Thiocolchicoside & Lornoxicam Tablets | Each film coated tablet contains Thiocolchicoside Lornoxicam Excipients Colour : Approved Colour used | IP IP | 4 8 Q.S | mg mg |
| Thiocolchicoside & Etoricoxib Tablets | Each film coated tablet contains Thiocolchicoside Etoricoxib Excipients Colour : Approved Colour used | IP IP | 8 60 Q.S | mg mg |
| Thiocolchicoside & Aceclofenac Tablets | Each film coated tablet contains Thiocolchicoside Aceclofenac Excipients Approved colour used | IP IP | 8 100 Q.S | mg |
| Torsemide Tablets IP 10 mg | Each uncoated tablet contains Torsemide Excipients | IP | 10 | mg |
| Torsemide Tablets IP 20 mg | Each uncoated tablet contains Torsemide Excipients | IP | 20 Q.S | mg |
| Torsemide & Spironolactone Tablets | Each uncoated tablet contains Torsemide Spironolactone Excipients | IP IP | 10 50 Q.S | mg mg |
| Torsemide & Spironolactone Tablets | Each film coated tablet contains Torsemide Spironolactone Approved Colour used Excipients | IP IP | 20 25 Q.S | mg mg |
| Trypsin Chymotrypsin, Diclofenac Potassium & Paracetamol Tablets | Each enteric coated tablet contains Trypsin Chymotrypsin (50000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin & chymotrypsin activity in a ratio of 6:1) Diclofenac Potassium Paracetamol Excipients Approved Colour used | BP IP | 5000 50 325 Q.S | AU mg mg |
| Voglibose, Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Glimepiride Metformin Hydrochloride (SR) Excipients Approved colour used | IP IP IP | 0.2 2 500 Q.S | mg mg mg |
| Aceclofenac , Paracetamol & Chlorzoxazone Tablets | Each film coated tablet contains Aceclofenac Paracetamol Chlorzoxazone Excipients Colour :Approved colour used | IP IP USP | 100 325 250 Q.S | mg mg mg |
| Aceclofenac (SR) Tablets | Each film coated tablet contains Aceclofenac (As sustained Release) Excipients Colour :Approved colour used | IP | 200 Q.S | mg |
| Albendazole & Ivermectin Tablets | Each chewable tablets contains Albendazole Ivermectin Excipients Colour : Erythrosine | IP IP | 400 12 Q.S | mg mg |
| Amlodipine Tablets IP | Each uncoated tablets contains Amlodipine Besylate Eq. to Amlodipine Excipients | IP | 5 Q.S | mg |
| Amlodipine & Atenolol Tablets | Each uncoated tablets contains Amlodipine Besylate Eq. to Amlodipine Excipients Atenolol | IP IP | 5 50 Q.S | mg mg |
| Deflazacort Tablets | Each uncoated tablet contains Deflazacort Excipients | 30 Q.S | mg | |
| Diclofenac Potassium & Serratiopeptidase Tablets | Each enteric coated tablet contains Diclofenac Potassium Serrationpeptidase ( As enteric coated Granules eq. to Enzymatic activity 20,000 units) Excipients Colour: Approved colour used | BP IP | 50 10 Q.S | mg mg |
| Domperidone & Cinnarizine Tablets | Each uncoated tablet contains Domperidone Maleate Eq. to Domperidone Cinnarizine Excipients | IP IP | 15 20 Q.S | mg mg |
| Drotaverine & Aceclofenac Tablets | Each film coated tablet contains Drotaverine Hydrochloride Aceclofenac Excipients Colour:Approved colour used | IP | 80 100 Q.S | mg mg |
| Etoricoxib Tablets IP 90 mg | Each film coated tablet contains Etoricoxib Excipients Approved colour used | IP | 90 Q.S | mg |
| Etoricoxib Tablets IP 120 mg | Each film coated tablet contains Etoricoxib Excipients Approved colour used | IP | 120 Q.S | mg |
| Etoricoxib & Paracetamol Tablets | Each film coated tablet contains Etoricoxib Paracetamol Excipients Colour: Approved colour used | IP IP | 60 500 Q.S | mg mg |
| Fexofenadine Hydrochloride Tablets IP 180 mg | Each film coated tablet contains Fexofenadine Hydrochloride Excipients Colour: Approved colour used | IP | 180 Q.S | mg |
| Fexofenadine Hydrochloride Tablets IP 120 mg | Each film coated tablet contains Fexofenadine Hydrochloride Excipients Colour: Approved Colour used | IP | 120 Q.S | mg |
| Flupentixol & Melitracen Tablets | Each film coated tablet contains Flupentixol Dihydrochloride Eq.to Flupentixol Melitracen Hydrochloride Excipients Approved Colour used | BP | 0.5 10 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients Approved Colour used | IP IP | 1 500 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients | IP IP | 2 500 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients | IP IP | 3 500 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients Approved Colour used | IP IP | 4 500 Q.S | mg mg |
| Glimepiride Tablets IP 2 mg | Each uncoated tablet contains Glimepiride Excipients Approved Colour used | IP | 2 Q.S | mg |
| Glucosamine Sulphate Potassium Chloride , Methyl Sulphonyl Methane & Diacerein Tablets | Each film coated tablet contains Glucosamine Sulphate Potassium Chloride Methyl Sulphonyl Methane Diacerein Excipients Approved Colour used | USP USP IP | 750 250 50 Q.S | mg mg mg |
| Ilaprazole Tablets 10 mg | Each gastro resistant tablet contains Ilaprazole Excipients Approved Colour used | IP | 10 Q.S | mg |
| Levetiracetam Tablets IP 500 mg | Each film coated tablet contains Levetiracetam Excipients Colour Titanium dioxide | IP | 500 Q.S | mg |
| Levocetirizine Dihydrochloride Tablets IP 5 mg | Each film coated tablet contains Levocetirizine Dihydrochloride Excipients Colour Titanium dioxide | IP IP | 5 Q.S | mg |
| Levofloxacin Tablets IP 250 mg | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Colour: Approved Colour used | IP | 250 Q.S | mg |
| Levofloxacin & Ornidazole Tablets | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Ornidazole Excipients Approved Colour used | IP IP | 250 250 Q.S | mg mg |
| Lornoxicam Tablets 8 mg | Each film coated tablet contains Lornoxicam Excipients Approved Colour used | 8 Q.S | mg | |
| Lornoxicam & Paracetamol Tablets | Each filmcoated tablet contains Lornoxicam Paracetamol Excipients Approved Colour used | IP | 8 325 Q.S | mg mg |
| Methylcobalamin & Gabapentin Tablets | Each film coated tablet contains Methylcobalamin Gabapentin Excipients Approved Colour used | IP USP | 500 300 | mg mg |
| Metformin Hydrochloride Sustained Release Tablets IP 500 mg | Each uncoated sustained release tablet contains Metformin Hydrochloride (as sustained release form) Excipients Colour : Titanium Dioxide | IP IP | 500 Q.S | mg |
| Mefenamic acid & Paracetamol Tablets | Each film coated tablets contains Mefenamic Acid Paracetamol Excipients Approved Colour used | IP IP | 500 325 Q.S | mg mg |
| Metaxalone & Diclofenac Potassium Tablets | Each film coated tablets contains Metaxalone Diclofenac Potassium Excipients Colour : Titanium dioxide | IP BP | 400 50 Q.S | mg mg |
| Paracetamol Tablets IP 650 mg V | Each uncoated tablets contains Paracetamol Excipients | IP | 650 Q.S | mg |
| Acyclovir Tablets IP 800 mg | Each uncoated dispersible tablets contains Acyclovir Excipients | IP | 800 Q.S | mg |
| Allopurinol Tablets IP 300 mg | Each uncoated tablets contains Allopurinol Excipients | IP | 300 Q.S | mg |
| Allopurinol Tablets IP 100 mg | Each uncoated tablets contains Allopurinol Excipients | IP | 100 Q.S | mg |
| Betahistine Dihydrochloride Sustained Release Tablets IP 24 mg | Each uncoated sustained release tablet contains: Betahistine Dihydrochloride Excipients | IP | 24 Q.S | mg |
| Artemether & Lumefantrine Tablets | Each uncoated tablet contains: Artemether Lumefantrine Excipients Colour : Approved Colour used | IP | 80 480 Q.S | mg mg |
| Escitalopram Oxalate Tablets IP 10 mg | Each film coated tablet contains Escitalopram Oxalate Eq. to Escitalopram Excipients Colour : Approved Colour used | IP | 10 Q.S | mg |
| Escitalopram Oxalate Tablets IP 20 mg | Each film coated tablet contains Escitalopram Oxalate Eq. to Escitalopram Excipients Colour : Approved Colour used | IP | 20 Q.S | mg |
| Esomeprazole Tablets IP 40 mg | Each Delayed Release tablet contains Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Colour : Approved Colour used | IP | 40 Q.S | mg |
| Hydroxyzine Hydrochloride Sustained Release Tablets IP 25 mg | Each sustained release tablet contains Hydroxyzine Hydrochloride Excipients | IP | 25 Q.S | mg |
| Ivermectin Tablets 12 mg | Each uncoated dispersible tablet contains Ivermectin Excipients Colour : Sunset Yellow FCF | IP | 12 Q.S | mg |
| Losartan Potassium Tablets IP 50 mg | Each film coated tablet contains Losartan Potassium Excipients Colour : Approved Colour used | IP | 50 Q.S | mg |
| Losartan Potassium & Hydrochlorothiazide Tablets IP | Each film coated tablet contains Losartan Potassium Hydrochlorothiazide Excipients Colour : Approved Colour used | IP IP | 50 12.5 Q.S | mg mg |
| Metoprolol Succinate Extended Release Tablets IP 50 mg | Each Exteneded release tablet contains Metoprolol Succinate Excipients Colour : Approved Colour used | IP | 50 Q.S | mg |
| Metoprolol Succinate Prolonged Release Tablets IP 25 MG | Each Prolonged Release tablet contains Metoprolol Succinate Excipients Approved colour used | IP | 25 Q.S | mg |
| Mirtazapine Tablets IP 15 mg | Each film coated tablet contains Mirtazapine Excipients Colour Titanium dioxide | IP | 15 Q.S | mg |
| Moxifloxacin Tablets 400 mg | Each film coated tablet contains Moxifloxacin Hydrochloride Eq. to Moxifloxacin Excipients Approved Colour used | IP | 400 Q.S | mg |
| Olanzapine Mouth Dissolving Tablets IP 10 mg | Each uncoated mouth dissolving tablets contains Olanzapine Excipients | IP | 10 Q.S | mg |
| Olanzapine Mouth Dissolving Tablets IP 5 mg | Each uncoated mouth dissolving tablet contains Olanzapine Excipients | IP | 5 Q.S | mg |
| Olmesartan Medoxomil Tablets IP 20 mg | Each film coated tablet contains Olmesartan Medoxomil Excipients Colour : Titanium Dioxide | IP IP | 20 Q.S | mg |
| Olmesartan Medoxomil & Hydrochlorthiazide Tablets IP | Each film coated tablets contains Olmesartan Medoxomil Hydrochlorthiazide Excipients Colour : Titanium Dioxide | IP IP IP | 20 12.5 Q.S | mg mg |
| Olmesartan Medoxomil Tablets IP 40 mg | Each film coated tablets contains Olmesartan Medoxomil Excipients Colour : Approved Colour used | IP | 40 Q.S | mg |
| Olmesartan Medoxomil & Hydrochlorthiazide Tablets IP | Each film coated tablets contains Olmesartan Medoxomil Hydrochlorthiazide Excipients Colour : Titanium Dioxide | IP IP IP | 40 12.5 Q.S | mg mg |
| Rabeprazole Sodium Tablets IP 20 mg | Each enteric coated tablets contains Rabeprazole Sodium Excipients Colour: Approved Colour used | IP | 20 Q.S | mg |
| Rabeprazole Sodium & Domperidone Tablets | Each enteric coated tablets contains Rabeprazole Sodium Domperidone Excipients Colour: Approved Colour used | IP IP | 20 10 Q.S | mg mg |
| Rifaximin Tablets 550 mg | Each film coated tablet contains Rifaximin Excipients Colour: Approved Colour used | BP | 550 Q.S | mg |
| Sertraline Tablets IP 50 mg | Each uncoated tablet contains Sertraline Hydrochloride Eq. to Sertraline Excipients | IP | 50 Q.S | mg |
| Tamsulosin Hydrochloride & Dutasteride Tablets | Each film coated tablet contains Tamsulosin Hydrochloride (as modified release) Dutasteride Excipients Colour: Approved Colour used | IP IP | 0.4 0.5 Q.S | mg mg |
| Losartan Potassium & Amlodipine Tablets | Each uncoated tablet contains Losartan Potassium Amlodipine Besylate Eq. to Amlodipine Excipients | IP IP | 50 5 Q.S | mg mg |
| Vildagliptin & Metformin HCl Tablets | Each film coated tablet contains Vildagliptin Metformin HCl Excipients Approved Colour used | IP | 50 850 Q.S | mg mg |
| Calcium Carbonate & Vitamin D3 Tablets IP | Each film coated tablet contains Calcium Carbonate Eq.to Elemental Calcium Vitamin D3 Excipients Approved Colour used | IP IP | 250 500 Q.S | mg mg |
| Calcium Citrate Maleate, Magnesium Hydroxide , Zinc Sulphate Monohydrate & Vitamin D3 Tablets | Each film coated tablet contains Calcium Citrate Maleate Magnesium Hydroxide Eq.to Elemental Magnesium Zinc Sulphate Monohydrate eq. to Elemental Zinc Vitamin D3 Excipients Approved Colour used | USP IP IP IP | 1000 1004 200 Q.S | mg mg L.U |
| Vitamin D3 Tablets IP | Each chewable tablet contains Vitamin D3 (Cholecalciferol) Excipients Approved Colour used | IP | 6000 Q.S | L.U |
| Rosuvastatin & Fenofibrate Tablets | Each filmcoated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Fenofibrate Excipients Colour: Approved Colour used | IP IP | 20 160 Q.S | mg mg |
| Doxophylline & Montelukast Sodium Tablets | Each uncoated sustained release tablet contains Doxophylline (as sustained release) Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 400 10 Q.S | mg mg |
| Clopidogrel Tablets I.P 75 mg | Each film coated tablet contains Clopidogrel Bisulphate Eq. to Clopidogrel Excipients Approved Colour used | IP | 75 Q.S | mg |
| Clopidogrel & Aspirin Tablets | Each film coated tablet contains Clopidogrel Bisulphate Eq. to Clopidogrel Aspirin Excipients Approved Colour used | IP IP | 75 75 Q.S | mg mg |
| Clopidogrel & Aspirin Tablets | Each film coated tablet contains Clopidogrel Bisulphate IP Eq. to Clopidogrel Aspirin Excipients Approved Colour used | IP IP | 75 150 Q.S | mg mg |
| Citicoline and Piracetam Tablets | Each film coated tablet contains: Citicoline Sodium eq.to Citicoline Piracetam Excipients Approved colour used | IP IP | 500 400 Q.S | mg mg |
| Cefpodoxime & Ofloxacin Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Ofloxacin Excipients Approved colour used | IP IP | 200 200 Q.S | mg mg |
| Cefpodoxime & Dicloxacillin (ER) Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Dicloxacillin Sodium Eq. to Dicloxacillin (as extended release) Excipients Approved colour used | IP IP | 200 500 Q.S | mg mg |
| Cefixime Trihydrate, Cloxacillin Sodium (ER) & Lactic Acid Tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to anhydrous Cefixime Cloxacillin Sodium Eq. to Cloxacillin (as extended release) Lactic Acid Bacillus Excipients Approved colour used | IP IP | 200 500 90 Q.S | mg mg mg Million Spores |
| Cefixime And Dicloxacillin Extended Release Tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Dicloxacillin Sodium Eq. to Dicloxacillin (as extended release) Excipients Approved colour used | IP IP | 200 500 Q.S | mg mg |
| Cefdinir Tablets 300 mg | Each film coated tablet contains Cefdinir Excipients Approved Colour used | USP | 300 Q.S | mg |
| Carbamazepine Sustained Release Tablets 200 mg | Each Sustained Release tablet contains Carbamazepine (As sustained release) Excipients | IP | 200 Q.S | mg |
| Atorvastatin & Telmisartan Tablets | Each film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Telmisartan Excipients Approved colour used | IP IP | 10 40 Q.S | mg mg |
| Atorvastatin & Amlodipine Tablets | Each film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Amlodipine Besylate Eq. to Amlodipine Excipients Approved colour used | IP IP | 10 5 Q.S | mg mg |
| Acyclovir Tablets IP 400 mg | Each uncoated dispersible tablet contains Acyclovir Excipients | IP | 400 Q.S | mg |
| Amisulpride Tablets IP 50 mg | Each uncoated tablet contains Amisulpride Excipients | IP | 50 Q.S | mg |
| Amisulpride Tablets IP 100 mg | Each uncoated tablet contains Amisulpride Excipients | IP | 100 Q.S | mg |
| Amisulpride Tablets IP 200 mg | Each uncoated tablet contains Amisulpride Excipients | IP | 200 Q.S | mg |
| Amlodipine, Olmesartan Medoxomil, Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Olmesartan Medoxomil Hydrochlorthiazide Excipients Approved colour used | IP IP IP | 10 40 25 Q.S | mg mg mg |
| Amlodipine & Telmisartan Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Excipients | IP IP | 10 40 Q.S | mg mg |
| Amlodipine & Telmisartan Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Excipients | IP IP | 10 80 Q.S | mg mg |
| Amlodipine, Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Hydrochlorothiazide Excipients | IP IP IP | 10 80 25 Q.S | mg mg mg |
| Amlodipine, Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Hydrochlorothiazide Excipients | IP IP IP | 5 40 12.5 Q.S | mg mg mg |
| Clopidogrel & Aspirin Tablets | Each film coated tablet contains Clopidogrel Bisulphate Eq. to Clopidogrel Aspirin Excipients Approved Colour used | IP IP | 300 150 Q.S | mg mg |
| Acarbose Tablets IP 50 mg | Each uncoated tablet contains Acarbose Excipients | IP | 50 Q.S | mg |
| Sparfloxacin Tablets 200 mg | Each film coated tablet contains Sparfloxacin Excipients Colour : Approved Colour used | 200 Q.S | mg | |
| Carvedilol Tablets IP 6.25 mg | Each uncoated tablet contains Carvedilol Excipients Approved Colour used | IP | 6.25 Q.S | mg |
| Carvedilol Tablets IP 3.125 mg | Each uncoated tablet contains Carvedilol Excipients Approved Colour used | IP | 3.125 Q.S | mg |
| Chlorthalidone Tablets IP 6.25 mg | Each uncoated tablet contains Chlorthalidone Excipients | IP | 6.25 Q.S | mg |
| Ebastine Tablets IP 20 mg | Each film coated tablet contains Ebastine Excipients Approved Colour used | IP | 20 Q.S | mg |
| Vitamin K2-7, Calcium Carbonate & Vitamin D3 Tablets | Each film coated tablet contains Vitamin K2-7 Calcium Carbonate Eq.to Elemental Calcium Vitamin D3 Excipients Approved Colour used | IP | 50 500 500 Q.S | mcg mg IU |
| Biotin Tablets 10 mg | Each film coated tablet contains Biotin Approved Colour used Excipients | BP | 10 Q.S | mg |
| Voriconazole Tablets IP 200 mg | Each film coated tablet contains Voriconazole Excipients Approved Colour used | IP | 200 Q.S | mg |
| Finasteride Tablets IP 5 mg | Each film coated tablet contains Finasteride Excipients Approved Colour Used | IP | 5 Q.S | mg |
| Fluconazole Tablets IP 400 mg | Each uncoated tablet contains Fluconazole Excipients | IP | 400 Q.S | mg |
| Thyroxine Sodium Tablets IP 50 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 50 Q.S | mg |
| Olopatadine Hydrochloride Tablets 5 mg | Each film coated tablet contains Olopatadine Hydrochloride Excipients Approved Colour Used | USP | 5 Q.S | mg |
| Norfloxacin & Tinidazole Tablets | Each film coated tablet contains Norfloxacin Tinidazole Excipients Approved Colour Used | IP IP | 400 600 Q.S | mg mg |
| Nebivolol Hydrochloride & Telmisartan Tablets | Each uncoated tablet contains Nebivolol Hydrochloride Eq. to Nebivolol Telmisartan Excipients | IP IP | 5 40 Q.S | mg mg |
| Metformin (SR) & Pioglitazone Tablets | Each uncoated tablet contains Metformin HCl (as sustained release form) Pioglitazone Hydrochloride Eq. to Pioglitazone Excipients | IP IP | 500 15 Q.S | mg mg |
| Loratadine Tablets 10 mg | Each uncoated tablet contains Loratadine Excipients | BP | 10 Q.S | mg |
| Labetalol Hydrochloride Tablets IP 100 mg | Each uncoated tablet contains Labetalol Hydrochloride Excipients | 100 Q.S | mg | |
| Hydroxyzine Hydrochloride Tablets IP 10 mg | Each film coated tablet contains Hydroxyzine Hydrochloride Excipients Approved Colour Used | IP | 10 Q.S | mg |
| Ofloxacin & Nitazoxanide Tablets | Each film coated tablet contains Ofloxacin Nitazoxanide Excipients Approved Colour Used | IP | 200 500 Q.S | mg mg |
| Olanzapine , Fluoxetine Hydrochloride Tablets | Each film coated tablet contains Olanzapine Fluoxetine Hydrochloride Excipients Approved Colour Used | IP USP | 10 20 Q.S | mg mg |
| Olanzapine Tablets IP 15 mg | Each film coated tablet contains Olanzapine Excipients | IP | 15 Q.S | mg |
| Olanzapine Tablets IP 7.5 mg | Each film coated tablet contains Olanzapine Excipients | IP | 7.5 Q.S | mg |
| Amlodipine & Olmesartan Medoxomil Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Olmesartan Medoxomil Approved colour used Excipients | IP IP | 5 20 Q.S | mg mg |
| Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets | Each film coated tablet contains Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended release form) Olmesartan Medoxomil Excipients Approved colour used | IP IP | 50 20 Q.S | mg mg |
| Olmesartan & Chlorthalidone Tablets | Each film coated tablet contains Chlorthalidone Olmesartan Medoxomil Excipients Approved colour used | IP IP | 12.5 20 Q.S | mg mg |
| Olmesartan & Chlorthalidone Tablets | Each film coated tablet contains Chlorthalidone Olmesartan Medoxomil Excipients Approved colour used | IP IP | 12.5 40 Q.S | mg mg |
| Olmesartan Medoxomil & Ramipril Tablets | Each film coated tablet contains Olmesartan Medoxomil Ramipril Excipients Approved Colour used | IP IP | 40 5 Q.S | mg mg |
| Olopatadine Hydrochloride & Ambroxol (SR) Tablets | Each film coated tablet contains Olopatadine Hydrochloride Ambroxol Hydrochloride Eq. to Ambroxol (as sustained release) Excipients Approved Colour Used | USP IP | 5 30 Q.S | mg mg |
| Ornidazole Tablets IP 500 mg | Each film coated tablet contains Ornidazole Excipients Colour : Tartrazine | IP | 500 Q.S | mg |
| Oxcarbazepine Tablets 150 mg | Each film coated tablet contains Oxcarbazepine Excipients Approved colour used | IP | 150 Q.S | mg |
| Oxcarbazepine Tablets 300 mg | Each film coated tablet contains Oxcarbazepine Excipients Approved colour used | IP | 300 Q.S | mg |
| Oxcarbazepine Tablets 450 mg | Each sustained release tablet contains Oxcarbazepine Excipients Approved colour used | IP | 450 Q.S | mg |
| Pantoprazole Gastro Resistant Tablets IP 20 mg | Each gastro resistant tablet contains Pantoprazole Sodium Eq. to Pantoprazole Excipients Approved colour used | IP | 20 Q.S | mg |
| Pentoxifylline Extended Release Tablets 400 mg | Each uncoated tablet contains Pentoxifylline (as extended release) Excipients | B.P | 400 Q.S | mg |
| Paroxetine Tablets 10 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 10 Q.S | mg |
| Paroxetine Tablets 20 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 20 Q.S | mg |
| Paroxetine Tablets 30 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 30 Q.S | mg |
| Paroxetine Tablets 40 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 40 Q.S | mg |
| Piroxicam & Paracetamol Tablets | Each film coated tablet contains Piroxicam Paracetamol Excipients Colour: Sunset Yellow FCF | IP IP | 20 500 Q.S. | mg mg |
| Ranolazine Extended Release Tablets 500 mg | Each Extended release tablet contains Ranolazine(As extended release) Excipients | 500 Q.S. | mg | |
| Pregabalin (SR) Tablets 150 mg | Each uncoated sustained release tablet contains Pregabalin Excipients | IP | 150 Q.S. | mg |
| Pregabalin (SR) Tablets 300 mg | Each uncoated sustained release tablet contains Pregabalin Excipients Colour: Approved Colour used | IP | 300 Q.S. | mg |
| Pregabalin (SR) & Methylcobalamin Tablets | Each uncoated tablet contains Pregabalin (as sustained release) Methylcobalamin Excipients | IP IP | 75 1500 Q.S. | mg mg |
| Propranolol Hydrochloride Tablets IP 20 mg | Each uncoated tablet contains Propranolol Hydrochloride Excipients | IP | 20 Q.S. | mg |
| Propranolol (SR) & Flunarizine Tablets | Each uncoated tablet contains Propranolol Hydrochloride(as sustained release) Flunarizine Dihydrochloride Excipients | IP BP | 40 10 Q.S. | mg mg |
| Quetiapine Tablets IP 25 mg | Each film coated tablet contains Quetiapine Fumarate Eq. to Quetiapine Excipients Colour : Yellow oxide of iron & Titanium dioxide | IP | 25 Q.S. | mg |
| Quetiapine Tablets IP 50 mg | Each film coated tablet contains Quetiapine Fumarate Eq. to Quetiapine Excipients Colour : Yellow oxide of iron & Titanium dioxide | IP | 50 Q.S. | mg |
| Quetiapine Tablets IP 100 mg | Each film coated tablet contains Quetiapine Fumarate Eq. to Quetiapine Excipients Colour : Yellow oxide of iron & Titanium dioxide | IP | 100 Q.S. | mg |
| Ramipril Tablets IP 2.5 mg | Each uncoated tablet contains Ramipril Excipients | IP | 2.5 Q.S. | mg |
| Ramipril Tablets IP 5 mg | Each uncoated tablet contains Ramipril Excipients | IP | 5 Q.S. | mg |
| Ramipril Tablets IP 10 mg | Each uncoated tablet contains Ramipril Excipients | IP | 10 Q.S. | mg |
| Ramipril & Hydrochlorothiazide Tablets IP | Each uncoated tablet contains Ramipril Hydrochlorothiazide Excipients | IP IP | 2.5 12.5 Q.S. | mg mg |
| Ramipril & Telmisartan Tablets | Each uncoated tablet contains Telmisartan Ramipril Excipients | IP IP | 40 2.5 Q.S | mg mg |
| Ramipril & Telmisartan Tablets | Each uncoated tablet contains Telmisartan Ramipril Excipients | IP IP | 40 5 Q.S | mg mg |
| Ranitidine Hydrochloride Tablets I.P 150 mg | Each film coated tablet contains Ranitidine Hydrochloride Eq. to Ranitidine Excipients Approved Colour Used | IP | 150 Q.S. | mg |
| Ranitidine Hydrochloride Tablets I.P 300 mg | Each film coated tablet contains Ranitidine Hydrochloride Eq. to Ranitidine Excipients Approved Colour Used | IP | 300 Q.S. | mg |
| Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each uncoated tablet contains Risperidone Trihexyphenidyl Hydrochloride Excipients | BP IP | 2 2 Q.S. | mg mg |
| Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each uncoated tablet contains Risperidone Trihexyphenidyl Hydrochloride Excipients | BP IP | 3 2 Q.S. | mg mg |
| Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each uncoated tablet contains Risperidone Trihexyphenidyl Hydrochloride Excipients | BP IP | 4 2 Q.S. | mg mg |
| Risperidone Tablets 1 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 1 Q.S. | mg |
| Risperidone Tablets 2 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 2 Q.S. | mg |
| Risperidone Tablets 3 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 3 Q.S. | mg |
| Risperidone Tablets 4 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 4 Q.S. | mg |
| Rosuvastatin Tablets IP 5 mg | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour :Approved colour used | IP | 5 Q.S. | mg |
| Rosuvastatin Tablets IP 40 mg | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour: Approved Colour used | IP IP | 40 Q.S. | mg |
| Roxithromycin Tablets IP 300 mg | Each film coated tablet contains Roxithromycin Excipients Colour: Approved Colour used | IP | 300 Q.S. | mg |
| Satranidazole & Ofloxacin Tablets | Each film coated tablet contains Satranidazole Ofloxacin Excipients Colour: Approved Colour used | IP | 300 200 Q.S. | mg mg |
| Sertraline Hydrochloride Tablets 100 mg | Each film coated tablet contains Sertraline Hydrochloride Eq. to Sertraline Excipients Colour :Approved colour used | BP | 100 Q.S. | mg |
| Sildenafil Citrate Tablets 50 mg | Each film coated tablet contains Sildenafil Citrate Eq. to Sildenafil Excipients Colour : Indigo caramine | 50 Q.S. | mg | |
| Sitagliptin Phosphate Tablets IP 50 mg | Each film coated tablet contains Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin Excipients Colour : Titanium Dioxide | IP | 50 Q.S. | mg |
| Sitagliptin Phosphate Tablets IP 100 mg | Each film coated tablet contains Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin Excipients Colour : Approved Colour used | IP | 100 Q.S. | mg |
| Sodium Feredetate, Folic Acid, Vit B12 & Zinc Sulphate Tablets | Each Film coated tablet contains Sodium Feredetate Eq. to Elemental Iron 33 mg Folic Acid Vit B12 Zinc Sulphate Monohydrate Eq. to Elemental Zinc Excipients Approved Colour used | BP IP IP IP | 231 1.5 15 11 Q.S. | mg mg mg mg |
| Sodium Feredetate, Folic Acid, Vit B12 Tablets | Each Film coated tablet contains Sodium Feredetate Eq. to Elemental Iron 33 mg Folic Acid Vit B12 Excipients Approved Colour used | BP IP IP IP | 231 1.5 15 Q.S | mg mg mg |
| Sultamicillin Tablets | Each Film coated tablet contains Sultamicillin (as Tosylate) Eq. to Sulbactum 147 mg & Ampicillin 220 mg Excipients Colour: Titanium Dioxide | PI IP | 375 Q.S. | mg |
| Tadalafil Tablets 10 mg | Each Film coated tablet contains Tadalafil Excipients Colour : Yellow Oxide of Iron | IP | 10 Q.S. | mg |
| Tadalafil Tablets 20 mg | Each Film coated tablet contains Tadalafil Excipients Colour : Yellow Oxide of Iron | IP | 20 Q.S. | mg |
| Telmisartan Tablets IP 20 mg | Each uncoated tablet contains Telmisartan Excipients Colour: Approved Colour used | IP | 20 Q.S. | mg |
| Amlodipine, Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Hydrochlorothiazide Excipients | IP IP IP | 2.5 20 6.25 Q.S. | mg mg mg |
| Terbinafine Tablets IP 250 mg | Each uncoated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Excipients | IP | 250 Q.S. | mg |
| Theophylline Prolonged Release Tablets 400 mg | Each prolonged Release uncoated tablet contains Theophylline Anhydrous (As prolonged release) Eq. to Theophylline Excipients | IP | 400 Q.S. | mg |
| Theophylline (SR) & Montelukast Tablets | Each uncoated tablet contains Theophylline Anhydrous (As sustained release) Eq. to Theophylline Montelukast Sodium Eq. to Montelukast Excipients | IP IP | 400 10 Q.S. | mg |
| Thiocolchicoside Tablets 4 mg | Each uncoated tablet contains Thiocolchicoside Excipients | IP | 4 Q.S. | mg |
| Thyroxine Sodium Tablets IP 12.5 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 12.5 Q.S. | mg |
| Thyroxine Sodium Tablets IP 25 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 25 Q.S. | mg |
| Thyroxine Sodium Tablets IP 75 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 75 Q.S. | mg |
| Thyroxine Sodium Tablets IP 100 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 100 Q.S. | mg |
| Tizanidine Hydrochloride & Aceclofenac Tablets | Each Film coated tablet contains Tizanidine Hydrochloride Eq. to Tizanidine Aceclofenac Excipients Approved Colour used | IP IP | 2 100 Q.S. | mg mg |
| Tofisopam Tablets 50 mg | Each uncoated tablet contains Tofisopam Excipients | JP | 50 Q.S. | mg |
| Tofisopam Tablets 100 mg | Each uncoated tablet contains Tofisopam Excipients | JP | 100 Q.S. | mg |
| Tolperison Hydrochloride & Diclofenac Sodium Tablets | Each film coated tablet contains Tolperison Hydrochloride Diclofenac Sodium Excipients Colour: Titanium Dioxide | JP IP IP | 150 50 Q.S. | mg mg |
| Tolperison Hydrochloride & Paracetamol Tablets | Each film coated tablet contains Tolperison Hydrochloride Paracetamol Excipients Colour: Titanium Dioxide | JP IP IP | 150 500 Q.S. | mg mg |
| Tolperison Tablets 150 mg | Each film coated tablet contains Tolperison Hydrochloride Excipients Colour: Titanium Dioxide | JP IP | 150 Q.S. | mg |
| Tolperison Sustained Release Tablets 450 mg | Each sustained release tablet contains Tolperison Hydrochloride Excipients Colour: Titanium Dioxide | JP IP | 450 Q.S. | mg |
| Tolperison Hydrochloride & Etodolac Tablets | Each uncoated tablet contains Tolperison Hydrochloride Etodolac Excipients Colour: Red Oxide of Iron | JP IP | 150 400 Q.S. | mg mg |
| Venlafaxine Hydrochloride Tablets 37.5 mg | Each uncoated tablet contains Venlafaxine Hydrochloride Excipients | BP | 37.5 Q.S. | mg |
| Venlafaxine Hydrochloride Tablets 75 mg | Each uncoated tablet contains Venlafaxine Hydrochloride Excipients | BP | 75 Q.S. | mg |
| Voglibose Tablets | Each uncoated tablet contains Voglibose Excipients | IP | 0.2 Q.S. | mg |
| Voglibose Tablets | Each uncoated tablet contains Voglibose Excipients | IP | 0.3 Q.S. | mg |
| Vitamin C Chewable Tablet | Each uncoated chewable tablet contains Ascorbic Acid Sodium Ascorbate eq. to Ascorbic Acid ExcipientsColour: Sunset Yellow FCF | IP IP | 100 450 400 Q.S. | mg mg mg |
| Telmisartan & Metprolol Succinate (ER) Tablets | Each uncoated tablet contains Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended Release) Excipients Colour : Red oxide of Iron | IP IP | 40 50 Q.S. | mg mg |
| Telmisartan & Metprolol Succinate (ER) Tablets | Each uncoated tablet contains Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended Release) Excipients Colour : Red oxide of Iron | IP IP | 20 25 Q.S. | mg mg |
| Teneligliptin & Metformin Hydrochloride (SR) Tablets | Each uncoated tablet contains Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin Hydrochloride (as Sustained Release) Excipients Approved Colour used | IP | 20 1000 Q.S. | mg mg |
| Ketoprofen & Thiocolchicoside Tablets | Each film coated tablet contains Ketoprofen Thiocolchicoside Excipients Approved Colour used | IP IP | 50 4 Q.S. | mg mg |
| Ebastine Tablets IP 10 mg | Each film coated tablet contains Ebastine Excipients Approved Colour used | IP | 10 Q.S. | mg |
| Labetalol Hydrochloride Tablets IP 50 mg | Each film coated tablet contains Labetalol Hydrochloride Excipients Colour : Sunset Yellow FCF | IP | 50 Q.S. | mg |
| Enalapril Maleate Tablets IP 10 mg | Each uncoated tablet contains Enalapril Maleate Excipients | IP | 10 Q.S. | mg |
| Enalapril Maleate & Hydrochlorothiazide Tablets | Each uncoated tablet contains Enalapril Maleate Hydrochlorothiazide Excipients | IP IP | 10 25 Q.S. | mg mg |
| Etoricoxib Tablets IP 60 mg | Each film coated tablet contains Etoricoxib Excipients Approved colour used | IP | 60 Q.S. | mg |
| Faropenem Sodium Tablets 450 mg | Each extended release tablet contains Faropenem Sodium Eq. to Faropenem Excipients Colour Titanium Dioxide | IP | 450 Q.S. | mg |
| Methylcobalamin & Gabapentin Tablets | Each film coated tablet contains Methylcobalamin Gabapentin Excipients Approved Colour used | IP USP | 500 100 Q.S. | mg mg |
| Gabapentin Extended Release Tablets 600 mg | Each film coated extended release tablet contains Gabapentin (As extended Release) Excipients Approved | IP | 600 Q.S. | mg |
| Glimepiride & Pioglitazone Hydrochloride Tablets | Each film coated tablet contains Glimepiride Pioglitazone Hydrochloride eq. to Pioglitazone Excipients Approved Colour used | IP IP | 1 15 Q.S. | mg mg |
| Labetalol Hydrochloride Tablets IP 200 mg | Each film coated tablet contains Labetalol Hydrochloride Excipients Colour : Sunset Yellow FCF | IP | 200 Q.S. | mg |
| Levofloxacin & Ambroxol Hydrochloride (SR) Tablets | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Ambroxol hydrochloride (As sustained Release) Excipients Approved Colour used | IP IP | 250 75 Q.S. | mg mg |
| Levofloxacin & Ambroxol Hydrochloride (SR) Tablets | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Ambroxol hydrochloride (As sustained Release) Excipients Approved Colour used | IP IP | 500 75 Q.S. | mg mg |
| Levosulpiride Tablets 50 mg | Each uncoated tablet contains Levosulpiride Excipients | IP | 50 Q.S. | mg |
| Levosulpiride Tablets 100 mg | Each uncoated tablet contains Levosulpiride Excipients | IP | 100 Q.S. | mg |
| Linagliptin & Metformin Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved colour used | IP | 2.5 500 Q.S. | mg mg |
| Linagliptin & Metformin Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved colour used | IP | 2.5 1000 Q.S. | mg mg |
| Losartan Potassium & Chlorthalidone Tablets | Each film coated tablet contains Losartan Potassium Chlorthalidone Excipients Colour Titanium dioxide | IP IP | 50 12.5 Q.S. | mg mg |
| Losartan Potassium & Atenolol Tablets | Each film coated tablet contains Losartan Potassium Atenolol Excipients Colour : Titanium dioxide | IP IP | 50 50 Q.S. | mg mg |
| Losartan Potassium & Chlorthalidone Tablets | Each film coated tablet contains Losartan Potassium Chlorthalidone Excipients Colour Titanium dioxide | IP IP | 25 6.25 Q.S. | mg mg |
| Mesalazine Prolonged Release Tablets | Each prolonged release film coated tablet contains Mesalazine (As prolonged release) Excipients Approved Colour used | IP | 1200 Q.S. | mg |
| Metformin (ER) & Pioglitazone Tablets | Each uncoated tablet contains Metformin HCl (as Extended Release form) Pioglitazone Hydrochloride Eq. to Pioglitazone Excipients | IP IP | 500 30 Q.S. | mg mg |
| Methylprednisolone Tablets 16 mg | Each uncoated tablet contains Methylprednisolone Excipients | IP | 16 Q.S. | mg |
| Metoprolol Succinate (ER) & Hydrochlorothiazide Tablets | Each uncoated tablet contains Metoprolol Succinate (As extended Release) Hydrochlorothiazide Excipients Approved colour used | IP IP | 50 12.5 Q.S. | mg mg |
| Metoprolol Succinate (ER) & Hydrochlorothiazide Tablets | Each uncoated tablet contains Metoprolol Succinate (As extended Release) Hydrochlorothiazide Excipients Approved colour used | IP IP | 25 12.5 Q.S. | mg mg |
| Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets | Each film coated tablet contains Metoprolol Succinate (As extended Release) Olmesartan Medoxomil Excipients Approved colour used | IP IP | 25 20 Q.S. | mg mg |
| Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets | Each film coated tablet contains Metoprolol Succinate (As extended Release) Olmesartan Medoxomil Excipients | IP IP | 50 20 Q.S. | mg mg |
| Mirtazapine Tablets IP 30 mg | Each film coated tablet contains Mirtazapine Excipients Colour Titanium dioxide | IP | 30 Q.S. | mg |
| Nebivolol Hydrochloride & Hydrochlorothiazide Tablets | Each Uncoated tablet contains Nebivolol Hydrochloride Eq. to Nebivolol Hydrochlorothiazide Excipients | IP IP | 5 12.5 Q.S. | mg mg |
| Nebivolol Hydrochloride Tablets IP 5 mg | Each uncoated tablet contains Nebivolol Hydrochloride Eq. to Nebivolol Excipients | IP | 5 Q.S. | mg |
| Nitrofurantoin Tablets IP 50 mg | Each film coated tablet contains Nitrofurantoin Excipients Approved colour used | IP | 50 Q.S. | mg |
| Nitrofurantoin Tablets IP 100 mg | Each film coated tablet contains Nitrofurantoin Excipients Approved colour used | IP | 100 Q.S. | mg |
| Acebrophylline & Acetylcysteine Tablets | Each film coated tablet contains Acebrophylline Acetylcysteine Excipients Approved Colour used | BP | 100 600 Q.S. | mg mg |
| Amlodipine, Telmisartan & Chlorthalidone Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Chlorthalidone Excipients Approved colour used | IP IP IP | 5 40 12.5 Q.S. | mg mg mg |
| Methylcobalamin,L- Methylfolate Calcium & Pyridoxal 5-Phosphate Tablets | Each film coated tablet contains Methylcobalamin L- Methylfolate Calcium Pyridoxal 5-Phosphate Excipients Approved colour used | IP USP USP | 1500 1 0.5 Q.S. | mg mg mg |
| Isoxsuprine Hydrochloride Sustained Release Tablets | Each film coated sustained release tablet contains : Isoxsuprine Hydrochloride Excipients Excipients | IP | 40 Q.S. | mg |
| Ebastine & Montelukast Sodium Tablets | Each film coated tablet contains Ebastine Montelukast Sodium Eq. to Montelukast Excipients Approved Colour used | IP IP | 10 10 Q.S. | mg mg |
| Aceclofenac, Paracetamol, Phenylephrine Hydrochloride, Cetirizine Hydrochloride & Caffeine Tablets | Each uncoated tablet contains : Aceclofenac Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Caffeine (Anhydrous) Excipients | IP IP IP IP IP | 100 325 5 10 25 Q.S. | mg mg mg mg mg |
| Sevelamer Carbonate Tablets 400 mg | Each film coated tablet contains Sevelamer Carbonate Excipients Colour : Approved Colour used | 400 Q.S. | mg | |
| Sevelamer Carbonate Tablets 800 mg | Each film coated tablet contains Sevelamer Carbonate Excipients Colour : Approved Colour used | 800 Q.S. | mg | |
| Rabeprazole Gastro Resistant Tablets 40 mg | Each Gastro Resistant tablet contains Rabeprazole Sodium Excipients Colour: Titanium Dioxide | IP IP | 40 Q.S. | mg |
| Disulfiram Tablets 200 mg | Each uncoated tablet contains Disulfiram Excipients | IP | 200 Q.S. | mg |
| Deflazacort Tablets 18 mg | Each uncoated tablet contains Deflazacort Excipients | 18 Q.S. | mg | |
| Diclofenac Sodium Sustained Release Tablets IP 100 mg | Each sustained release tablet contains Diclofenac Sodium Excipients Approved Colour used | IP | 100 Q.S. | mg |
| Vitamin C, Zinc Citrate , Selenium Tablets | Each Chewable tablet contains Vitamin C Zinc Citrate Selenium Excipients Approved Colour used | 500 2.2 600 Q.S. | mg mg mg |
|
| Telmisartan, Cilnidipine & Chlorthalidone Tablets | Each film coated tablet contains Telmisartan Cilnidipine Chlorthalidone Excipients Colour : Ferric oxide (Red) USP NF | IP IP | 40 10 6.25 Q.S. | mg mg mg |
| Metformin Hydrochloride(SR) & Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride Eq. to Metformin (As sustained release) Repaglinide Excipients Approved colour used | IP BP | 500 1 Q.S. | mg mg |
| Metformin Hydrochloride(SR) & Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride Eq. to Metformin(As sustained release) Repaglinide Excipients Approved colour used | IP BP | 500 2 Q.S. | mg mg |
| Nimesulide Tablets 100 mg | Each uncoated tablet contains Nimesulide Excipients | BP | 100 Q.S. | mg |
| Nitroglycerin Controlled Release Tablets 6.4 mg | Each uncoated tablet contains Diluted Nitroglycerin Eq. to Nitroglycerin (In Controlled Release form) Excipients Colour: Lake of Erythrosine | IP | 6.4 Q.S. | mg |
| Metoprolol Succinate Prolonged Release & Amlodipine Tablets IP | Each film coated tablet contains Metoprolol Succinate Equiv. to Metoprolol Tartrate (As prolonged release) Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used | IP IP | 47.5 50 5 Q.S. | mg mg mg |
| Amoxycillin Tablets 500 mg | Each film coated tablet contains Amoxycillin Trihydrate Eq.to Amoxycillin Excipients Approved Colour Used | IP | 500 Q.S. | mg |
| Calcitriol, Calcium Carbonate & Zinc Sulphate Monohydrate Tablets | Each film coated tablet contains Calcitriol Calcium Carbonate eq. to Elemental Calcium Zinc Sulphate Monohydrate eq. to elemental Zinc Excipients Approved Colour Used | IP IP IP | 0.25 1250 500 7.5 Q.S. | mg mg mg mg |
| Cefixime Dispersible Tablets 400 mg | Each dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Excipients | IP | 400 Q.S. | mg |
| Cephalexin dispersible tablets IP 250 mg | Each dispersible tablet contains Cephalexin eq.to anh. Cephalexin Excipients Colour: Tartrazine Each hard gelatin capsule contains | IP | 250 Q.S. | mg |
| Rabeprazole Sodium & Ondansetron Tablets | Each gastro resistant tablet contains Rabeprazole Sodium Eq. to Rabeprazole Ondansetron HCl Eq. to Ondansetron Excipients Colour : Sunset Yellow FCF | IP IP | 20 4 Q.S. | mg mg |
| Dapagliflozin Tablets 10 mg | Each film coated tablet contains Dapagliflozin Propanediol Monohydrate eq.to Dapagliflozin Excipients Colour: Titanium Dioxide | IP | 10 Q.S. | mg |
| Deflazacort Tablets | Each uncoated tablet contains Deflazacort Excipients | 12 Q.S. | mg | |
| Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains: Diclofenac Potassium Paracetamol Chlorzoxazone Excipients Approved Colour used | IP IP USP | 50 325 500 Q.S. | mg mg mg |
| Divalproex Extended Release Tablets IP 250 mg | Each extended release tablet contains Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used | IP | 250 Q.S. | mg |
| Divalproex Extended Release Tablets IP 500 mg | Each extended release tablet contains Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used | IP | 500 Q.S. | mg |
| Zinc Acetate Tablets | Each enteric coated tablet contains Zinc Acetate (as dihydrate) Eq. to elemental Zinc Excipients Approved Colour used | USP | 167.86 50 Q.S. | mg mg |
| Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablet | Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablet Ferrous ascorbate eq. to Elemental iron Folic acid Zinc Sulphate monohydrate Eq. to Elemental Zinc Excipients Approved colour used | IP | 100 1.5 22.5 Q.S. | mg mg mg |
| Nitroglycerine sustained Release Tablets 2.6 mg | Each sustained release tablet contains Nitroglycerine Excipients Colour: Lake of Erythrosine | IP | 2.6 Q.S. | mg |
| Pancreatin, Simethicone & Activated Charcoal Tablets | Each film coated tablet contains Pancreatin Simethicone Activated Charcoal Excipients Approved colour used | IP IP IP | 175 50 50 Q.S. | mg mg |
| Paracetamol SR 1000mg Tablets | Each sustained release bilayered tablet contains Paracetamol Excipients | IP | 1000 Q.S. | mg |
| Paracetamol & Domperidone Tablets | Each uncoated dispersible tablet contains Paracetamol Domperidone Excipients | IP IP | 35 10 Q.S | mg mg |
| Paracetamol , Phenylephrine HCl, Levocetirizine, Chlorpheniramine Maleate Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Levocetirizine Dihydrochloride Chlorpheniramine Maleate Excipients Colour: approved colour used | IP IP IP IP | 500 5 5 4 Q.S. | mg mg mg mg |
| Pregabalin, Methylcobalamin & Nortriptyline Tablets | Each film coated tablet contains Pregabalin Methylcobalamin Nortriptyline HCl Eq. to Nortriptyline Excipients Colour: Approved Colour used | IP IP IP | 75 1500 10 Q.S. | mg mg mg |
| Thiocolchicoside & Aceclofenac Tablets | Each film coated tablet contains Thiocolchicoside Aceclofenac Excipients Approved colour used | IP IP | 4 100 Q.S. | mg mg |
| Levocetirizine & Montelukast Sodium dispersible Tablets | Each uncoated dispersible tablets contains Levocetirizine Dihydrochloride Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 2.5 4 Q.S. | mg mg |
| Cilnidipine & Olmesartan Medoxomil Tablets | Each film coated tablet contains Olmesartan Medoxomil Cilnidipine Excipients Approved colour used | IP IP | 20 10 | mg mg |
| Albendazole Chewable Tablets 200mg | Each chewable tablet contains Albendazole Excipients | IP | 200 Q.S. | mg |
| Amlodipine Besylate & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate eq. to Amlodipine Hydrochlorothiazide Excipients | IP IP | 5 12.5 Q.S. | mg mg |
| Losartan Potassium & Amlodipine Tablets | Each uncoated tablet contains Losartan Potassium Amlodipine Besylate eq. to Amlodipine Excipients | IP IP | 25 5 Q.S. | mg mg |
| Metoprolol Succinate Prolonged release & Amlodipine Tablets IP | Each film coated tablet contains Metoprolol Succinate( as Prolonged release ) equiv. to Metoprolol Tartrate Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used | IP IP | 25 5 Q.S. | mg mg |
| Bisoprolol fumarate 5mg & Amlodipine 5mg Tablets | Each film coated tablet contains Bisoprolol fumarate Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used | IP IP | 5 5 Q.S. | mg mg |
| Amlodipine besylate & Nebivolol Hydrochloride Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Nebivolol Hydrochloride Eq. to Nebivolol Excipients | IP IP | 5 5 Q.S. | mg mg |
| Amlodipine besylate Tablets 10 mg | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Excipients | IP | 10 Q.S. | mg |
| Amlodipine besylate & Nebivolol Hydrochloride Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Nebivolol Hydrochloride Eq. to Nebivolol Excipients | IP IP | 10 5 Q.S. | mg mg |
| Amlodipine, Valsartan & Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Valsartan Hydrochlorothiazide Excipients Approved Colour used | IP IP | 5 320 2.5 Q.S. | mg mg mg |
| Amlodipine, Valsartan & Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Hydrochlorothiazide Valsartan Excipients Approved Colour used | IP USP IP | 2.5 80 12.5 Q.S. | mg mg mg |
| Amlodipine, Valsartan & Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Valsartan Hydrochlorothiazide Excipients Approved Colour used | IP USP IP | 10 325 25 Q.S. | mg mg mg |
| Amoxycillin dispersible Tablets IP 125 mg | Each dispersible tablet contains Amoxycillin Trihydrate Eq.to Amoxycillin Excipients Approved Colour used | IP | 125 Q.S. | mg |
| Artemether & Lumefantrine Tablets | Each uncoated tablet contains Artemether Lumefantrine Excipients | IP | 20 120 Q.S. | mg mg |
| Artemether & Lumefantrine Tablets | Each uncoated tablet contains Artemether Lumefantrine Excipients | IP | 40 240 Q.S. | mg mg |
| Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Ezetimibe Excipients Approved Colour used | IP IP | 10 10 Q.S. | mg mg |
| Azithromycin Dispersible tablets 100 mg | Azithromycin (as dihydrate ) Eqv.to anhydrous Azithromycin Excipients | IP | 100 Q.S. | mg |
| Etodolac Prolonged Release tablets IP | Etodolac Excipients approved colour used | IP | 600 Q.S. | mg |
| Benidipine Hydrochloride Tablets 4 mg | Each film coated tablet contains Benidipine Hydrochloride Excipients Approved Colour used | 4 Q.S. | mg | |
| Benidipine Hydrochloride Tablets 8 mg | Each film coated tablet contains Benidipine Hydrochloride Excipients Approved Colour used | 8 Q.S. | mg | |
| Bisoprolol Fumarate Tablets | Bisoprolol Fumarate Excipients Approved Colour used | USP | 2.5 Q.S. | mg |
| Bisoprolol Fumarate Tablets | Bisoprolol Fumarate Excipients Approved Colour used | USP | 2.5 Q.S. | mg |
| Cefixime (SR) 400 mg & Moxifloxacin (SR) 400 mg Tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to anhydrous Cefixime Moxifloxacin HCl Eq. to Moxifloxacin Excipients Approved colour used | IP IP | 400 400 Q.S. | mg mg |
| Baclofen Tablets 25 mg | Each uncoated tablet contains Baclofen Excipients | USP | 25 Q.S. | mg |
| Fluoxetine Hydrochloride and Olanzapine Tablets | Each Uncoated tablet contains Fluoxetine Hydrochloride Olanzapine Excipients Approved colour used | USP IP | 20 5 Q.S. | mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 300 8 Q.S. | mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 300 4 Q.S. | mg mg |
| Etodolac and Paracetamol Tablets | Each film coated tablet contains Etodolac Paracetamol Excipients Approved colour used | IP IP | 300 500 Q.S. | mg mg |
| Doxofylline (SR) & Montelukast Sodium Tablets | Each uncoated sustained release Tablet contains Doxofylline (as sustained release) Montelukast Sodium eq. to Montelukast Excipients | IP IP | 800 10 Q.S. | mg mg |
| Divalproex Extended Release Tablets IP 750 mg | Each extended release tablet contains Divalproex Sodium Eq. to available Valproic Acid Excipients Approved colour used | IP | 750 Q.S. | mg |
| Diltiazem Hydrochloride SR Tablets IP 90 mg | Each film coated sustained release tablet contains Diltiazem Hydrochloride Excipients Approved colour used | IP | 90 Q.S. | mg |
| Diclofenac Sodium SR Tablets IP 150 mg | Each sustained release tablet contains Diclofenac Sodium Excipients Approved colour used | IP | 150 Q.S. | mg |
| Cefixime & Sulbactum Tablets | Each film coated tablets contains Cefixime (Eq. to Anhydrous Cefixime) Sulbactum Sodium Eq. to Sulbactum Excipients approved colour used | IP BP | 200 150 Q.S. | mg mg |
| Dexibuprofen & Paracetamol Tablets | Each uncoated tablet contains Dexibuprofen Paracetamol Excipients | IP | 300 500 Q.S. | mg mg |
| Dapoxetine Hydrochloride Tablets IP 30 mg | Each film coated tablet contains Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Approved colour used | IP | 30 Q.S. | mg |
| Dapoxetine Hydrochloride Tablets IP 60 mg | Each film coated tablet contains Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Approved colour used | IP | 60 Q.S. | mg |
| Clotrimazole Vaginal Tablets IP 100 mg | Each uncoated vaginal tablet contains Clotrimazole Excipients | IP | 100 Q.S. | mg |
| Cefpodoxime & Dicloxacillin (ER) Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Dicloxacillin Sodium Eq. to Dicloxacillin (as extended release) Excipients Approved colour used | IP IP | 100 500 Q.S. | mg mg |
| Cefixime,Azithromycin and lactic acid Bacillus Tablets | Each film coated tablet contains Cefixime (as trihydrate) eq. to anh cefixime Azithromycin dihydrate eq. to (anh) Azithromycin lactic acid bacillus excipients Colour: approved colour used | IP IP | 200 250 60 Q.S. | mg mg Million spores |
| Azithromycin oral suspension IP | Each 5 ml contains: Azithromycin Dihydrate eq. to (anh) Azithromycin In a flavoured syrupy base Excipients approved colour used | IP | 100 Q.S. | mg mg |
| Azithromycin & Lactic acid Bacillus Tablets | Each filmcoated Tablet contains: Azithromycin Dihydrate eq. to (anh) Azithromycin lactic acid bacillus excipients Colour ponceau 4R | IP | 500 60 Q.S. | mg mg Million spores |
| Acotiamide Tablets 100 mg | Each film coated tablet contains Acotiamide hydrochloride hydrate Excipients Approved colour used | 100 Q.S. | mg | |
| Rivaroxaban Tablets 20 mg | Each film coated tablet contains Rivaroxaban Micronized Excipients Approved colour used | 20 Q.S. | mg | |
| Tolperisone Hydochloride & Paracetamol Tablets | Each film coated tablet contains Tolperisone Hydochloride Paracetamol Excipients Approved colour used | IP | 150 500 Q.S. | mg mg |
| Cilnidipine & Metoprolol Succinate ER Tablets | Each film coated bilayered tablet contains Cilnidipine Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended release) Excipients Approved colour used | IP IP | 10 47.5 50 Q.S. | mg mg mg |
| Clomiphene Citrate Tablets IP 50 mg | Each uncoated tablet contains Clomiphene Citrate Excipients | IP | 50 Q.S. | mg |
| Torsemide & Spironolactone Tablets | Each film coated tablet contains Torsemide Spironolactone Excipients Approved Colour used | IP IP | 20 50 Q.S. | mg mg |
| Calcium Citrate, Magnesium Hydroxide , Zinc Sulphate Monohydrate & calcitriol tablets | Each film coated tablet contains Calcium Citrate Magnesium hydroxide Eq.to Elemental Magnesium Eq.to Elemental Zinc Calcitriol Excipients Approved Colour used | USP IP IP IP | 750 100 7.5 0.25 Q.S. | mg mg mg mg |
| Paracetamol suspension IP 150 mg | Each ml contains Paracetamol flavoured syrupy base Approved Colour used Colour : Yellow Oxide of Iron | IP | 150 Q.S. | |
| Trypsin, Bromelain, Rutoside Trihydrate & Aceclofenac Tablets | Each enteric coated tablet contains Trypsin Bromelain Rutoside Trihydrate Aceclofenac Excipients approved colour used | BP BP IP | 48 90 100 100 Q.S. | mg mg mg mg |
| Trypsin, Bromelain, Rutoside Trihydrate & DIclofenac Sodium Tablets | Each enteric coated tablet contains Trypsin Bromelain Rutoside Trihydrate Excipients approved colour used | BP BP | 48 90 100 Q.S. | mg mg mg |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | Each enteric coated tablet contains Trypsin Bromelain Rutoside Trihydrate Excipients approved colour used | BP BP | 96 180 200 Q.S. | mg mg mg |
| Voglibose, Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Glimepiride Metformin Hydrochloride (SR) Excipients Approved colour used | IP IP IP | 0.3 1 500 Q.S. | mg mg mg |
| Voglibose, Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Glimepiride Metformin Hydrochloride (SR) Excipients Approved colour used | IP IP IP | 0.3 2 500 Q.S. | mg mg mg |
| Ofloxacin & Flavoxtate Tablets | Each film coated tablet contains Ofloxacin Flavoxtate Hydrochloride Excipients Approved colour used in coating | IP IP | 200 200 Q.S. | mg mg |
| Flunarizine, Domperidone and Paracetamol Tablets | Each film coated tablet contains Flunarizine Dihydrochloride Eq.to Flunarizine Domperidone Paracetamol Excipients Approved colour used in coating | BP IP | 5 10 325 Q.S. | mg mg mg |
| Flupenthixol Tablets | Each film coated tablet contains Flupenthixol Dihydrochloride Eq.to Flupenthixol Excipients Approved colour used in coating | BP | 0.5 Q.S. | mg |
| Quetiapine Tablets IP 25 mg | Approved colour used in coating Each film coated tablet contains Quetiapine fumarate Eq.to Quetiapine Excipients Approved colour used | IP | 25 Q.S. | mg |
| Chlorthalidone , Amlodipine & Telmisartan Tablets | Each film coated tablet contains Chlorthalidone Amlodipine besylate Eq.to amlodipine Telmisartan Hydrochloride Excipients Approved colour used | IP IP IP | 12.5 5 80 Q.S. | mg mg mg |
| Prochlorperazine Maleate Tablets IP | Each film coated tablet contains Prochlorperazine Maleate Excipients Approved colour used | IP | 5 Q.S | mg |
| Sulfasalazine USP 500 mg Tablet | Each Delayed release tablet contains Sulfasalazine Excipients Approved colour used | USP | 500 Q.S. | mg |
| Griseofulvin Tablets IP 500mg | Each uncoated tablet contains Griseofulvin Excipients | IP | 500 Q.S. | mg |
| Lansoprazole orally Disintegrate Tablets 15 mg | Each orally disintegrate tablet contains Lansoprazole ( as sustained release pellets) Excipients Approved colour used | IP | 15 Q.S. | mg |
| Lansoprazole orally Disintegrate Tablets 30mg | Lansoprazole ( as sustained release pellets) Excipients Approved colour used | IP | 30 Q.S. | mg |
| Calcium citrate maleate , Vitamin k2-7 ,Calcitriol ,Zinc sulphate monohydrate tablets | Each film coated tablet contains Calcium Citrate Maleate Eq. to Elemental Calcium Calcitriol vitamin K2-7 Zinc sulphate monohydrate Excipients Approved colour used | IP IP | 1200 250 0.25 45 7.5 Q.S. | mg mg mg mg mg |
| Satranidazole Tablets | Each film coated tablet contains Satranidazole Excipients Approved color used | IP | 300 Q.S. | mg |
| Paracetamol and Chlorpheniramine Maleate & Phenylephrine Syrup | Each 5 ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride flavoured syrupy base | IP IP IP | 250 2 5 Q.S. | mg mg mg |
| Diacerein, Glucosamine Sulphate, Potassium chloride Tablets | Each film coated tablet contains Diacerein Glucosamine Sulphate Potassium chloride Excipients Approved color used | IP USP | 50 750 Q.S. | mg mg |
| Ginko Biloba, Piracetam & Vinopocetine Tablets | Each film coated tablet contains Ginko Biloba extract Piracetam Vinopocetine Excipients | IP | 60 800 5 Q..S. | mg mg mg |
| Cefixime, Dicloxacillin Sodium & Lactic Acid Bacillus Tablets | Each film coated tablet contains Cefixime (Eq. to Anhydrous Cefixime) Dicloxacillin Sodium Eq. to Dicloxacillin (As Extended release) Lactic Acid Bacillus Excipients Approved color used | IP IP | 200 500 90 Q.S. | mg mg Million Spores |
| Saxagliptin 2.5mg + Metformin HCl 500mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Metformin HCl Excipients Approved color used | IP | 2.5 500 Q.S. | mg mg |
| Saxagliptin 5 mg + Metformin HCl 500 mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Metformin HCl Excipients Approved color used | IP | 5 500 Q.S. | mg mg |
| Sodium Picosulfate 10mg tablets | Each Uncoated tablet contains Sodium Picosulfate Excipients | BP | 10 Q.S. | mg |
| Saxagliptin 2.5 mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Excipients Approved color used | 2.5 Q.S. | mg | |
| Saxagliptin 5.0 mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Excipients Approved color used | 5 Q.S. | mg | |
| Cefixime, Oflaxacin & Lactic Acid Bacillus tablets | Each film coated tablet contains Cefixime (as Trihydrate) (Eq. to Anhydrous Cefixime) Oflaxacin Lactic Acid Bacillus Excipients Approved color used | IP IP | 200 200 60 Q.S. | mg mg mg |
| Nevibolol Hydrochloride Tablets 10 mg | Each uncoated tablet contains Nevibolol Hydrochloride Eq. to Nevibolol Excipients | IP | 10 Q.S. | mg |
| Pancreatin, Simethicone & Activated Charcoal Tablets | Each film coated tablet contains Pancreatin Simethicone Activated Charcoal Excipients Approved color used | IP IP IP | 175 50 50 Q.S. | mg mg mg |
| Terbinafine Tablets USP 500mg | Each uncoated tablet contains Terbinafine Hydrochloride Eq. Terbinafine Excipients | USP | 500 Q.S. | mg |
| Acarbose Tablets IP 25 mg | Each film coated tablet contains Acarbose Excipients Approved color used | IP | 37.5 Q.S. | mg |
| Sulphamethoxazole & Trimethoprim Tablets | Each film coated tablet contains Sulphamethoxazole Trimethoprim Excipients Approved color used | IP IP | 800 160 Q.S. | mg mg |
| N-Acetyl -L-cysteine & Ambroxol Hydrochloride Tablets | Each Film coated tablet contains N-Acetyl L-cysteine Ambroxol Hydrochloride Excipients Excipients | USP IP | 200 30 Q.S. | mg mg |
| Omeprazole Magnesium & Ondansetron Hydrochloride Tablets | Each Film coated tablet contains Omeprazole Magnesium Eq. to Omeprazole Ondansetron Hydrochloride Eq. to Ondansetron Excipients Approved color used | IP IP | 10 4 Q.S. | mg mg |
| Methylcobalamin, L- Methylfolate Calcium & Pyridoxal 5-sulphate Tablets | Each film coated tablet contains Methylcobalamin L- Methylfolate calcium Pyridoxal 5-sulphate Excipients Approved colour used | IP USP USP | 1500 1 5 Q.S. | mg mg mg |
| Amoxycillin + Clavulanic acid tablets | Each film coated tablet contains Potassium Clavulanate eq. to Clavulanic acid Amoxycillin Trihydrate eq.to of Amoxycillin Excipients Approved colour used | IP IP | 125 250 Q.S. | mg mg |
| Amoxycillin + Clavulanic acid tablets | Each film coated tablet contains Potassium Clavulanate eq. to Clavulanic acid Amoxycillin Trihydrate eq.to of Amoxycillin Excipients Approved colour used | IP IP | 125 875 Q.S. | mg mg |
| Metformin Hydrochloride(SR), Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride (As sustained release Form) Repaglinide Excipients Approved colour used | IP IP | 500 1 Q.S. | mg mg |
| Metformin Hydrochloride(SR), Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride As sustained release Form Repaglinide Excipients Approved colour used | IP IP | 500 2 Q.S. | mg mg |
| Omeprazole Magnesium and Ondansteron HCl Tablets | Each film coated tablet contains Omeprazole Magnesium Eq. to Omeprazole Ondansteron HCl Eq. to Ondansteron ExcipientsApproved colour used | IP | 40 10 Q.S. | mg mg |
| S-Adenosyl-L-Methionine Tablet | Each Film Coated Tablet Contains S-Adenosyl-L-Methionine Excipients Approved colour used in coating | 400 Q.S. | mg | |
| Acetylcysteine tablets | Each Effervescent Tablet Contains Acetylcysteine Excipients Approved colour used in coating | USP | 600 Q.S. | mg |
| Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablet | Each Film Coated Tablet Contains Cetirizine Hydrochloride Phenylephrine Hydrochloride Excipients Approved colour used in coating | IP IP | 5 10 Q.S. | mg mg |
| Bepotastine Besilate Tablets | Each film coated tablet contains Bepatostine Besilate Excipients Approved colour used in coating | 10 Q.S. | mg | |
| Mefenamic Acid, Paracetamol & Dicyclomine Hydrochloride Tablets | Each uncoated tablet contains Mefenamic Acid Paracetamol Dicyclomine Hydrochloride Excipients | IP IP IP | 250 325 10 Q.S. | mg mg mg |
| Doxylamine Succinate & Pyridoxine HCl Tablets | Each enteric coated Tablet contains Doxylamine Succinate Pyridoxine HCl Excipients Approved colour used | USP IP | 10 10 Q.S. | mg mg |
| Methylcobalamin Tablet | Each film coated tablet contains Methylcobalamin Excipients Approved colour used | IP | 1500 Q.S. | mcg |
| Loratadine Tablets | Each uncoated Tablet contains Loratadine Excipients Approved colour used | BP | 10 Q.S. | mg |
| Serratiopeptidase Tablets | Each film coated Tablet contains Serratiopeptidase Excipients Approved colour used | IP | 10 Q.S. | mg |
| Ofloxacin Tablets | Each Film coated Tablet contains Ofloxacin Excipients Approved colour used in coating | IP | 400 Q.S. | mg |
| Cefuroxime Axetil Tablets IP | Each Film coated Tablet contains Cefuroxime Axetil Eq. to Cefuroxime Excipients Approved colour used in coating | IP | 250 Q.S. | mg |
| Cefpodoxime Proxetil Tablets IP | Each Film coated Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used in coating | IP | 200 Q.S. | mg |
| Ursodeoxycholic Acid Tablets IP 150 mg | Each uncoated Tablet contains Ursodeoxycholic acid Excipients | IP | 150 Q.S. | mg |
| Pantoprazole Sodium & Domperidone tablets | Each Enteric coated tablet contains Pantoprazole Sodium Eq. to Pantaprazole Domperidone Excipients Approved colour used | IP BP | 40 10 Q.S. | mg mg |
| Azithromycin Tablets IP 500 mg | Each Film coated tablet contains Azithromycin Dihydrate Eq. to Azithromycin Excipients Approved colour used in coating | IP | 500 Q.S. | mg |
| Aspirin Dispersible Tablets IP 75 mg | Each Dispersible tablet contains Aspirin Excipients | IP | 75 Q.S. | mg |
| Aspirin Dispersible Tablets IP 150 mg | Each Dispersible tablet contains Aspirin Excipients | IP | 150 Q.S. | mg |
| Ofloxacin & Lactic Acid Bacillus Tablets | Each Film Coated Tablet contains Ofloxacin Lactic Acid Bacillus Excipients Approved colour used in coating | IP | 200 60 Q.S. | mg Million Spores |
| Prochlorperazine Maleate Mouth Dissolving Tablet | Each Uncoated Mouth Dissolving Tablet contains Prochlorperazine Maleate Excipients | IP | 5 Q.S. | mg |
| Rivaroxaban Tablets 10 mg | Each film coated tablet contains Rivaroxaban Excipients Approved colour used | 10 Q.S. | mg | |
| Rivaroxaban Tablet 15 mg | Each film coated tablet contains Rivaroxaban Excipients Approved colour used | 15 Q.S. | mg | |
| Cinnarizine Sustained Release Tablet | Each Sustained Release Tablet contains Cinnarizine Excipients Approved colour used | IP | 75 Q.S. | mg |
| Azithromycin & Lactic Acid bacillus Tablets | Each Film coated Tablet contains Azithromycin Dihydrate Eq. to Azithromycin Anhydrous Lactic Acid Bacilus Excipients Approved colour used | IP | 250 60 Q.S. | mg Million Spores |
| Ascorbic Acid, Sodium Ascorbate and Zinc Chewable Tablets | Each Chewable Tablet contains Ascorbic Acid Sodium Ascorbate Eq. to Ascorbic Acid Zinc Citrate Zinc Citrate Excipients Approved colour used | IP IP IP | 100 450 400 5 Q.S. | mg mg mg mg |
| Paracetamol, Phenylephrine HCl, Caffeine & Diphenhydramine Hydrochloride Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Caffeine anhydrous Eq. to Caffeine Diphenhydramine Hydrochloride Excipients | IP IP IP IP | 325 5 30 25 Q.S. | mg mg mg mg |
| L-Ornithine L-Aspartate & Pancreatin Tablets | Each Film coated tablet contains L-Ornithine L-Aspartate Pancreatin Excipients Approved colour used | IP | 150 100 Q.S. | mg mg |
| Terbinafine Hydrochloride & Itraconazole Tablets | Each Film coated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Itraconazole Excipients Approved colour used | IP BP | 250 200 Q.S. | mg mg |
| Doxycycline Hydrochloride & Lactic Acid Bacillus Tablets | Each Film coated tablet contains Doxycycline Hydrochloride Eq. to Doxycycline Lactic Acid Bacillus Excipients Approved colour used | IP | 100 90 Q.S. | mg mg Million Spores |
| Rosuvastatin Calcium & Clopidogrel Bisulphate tablets | Each Film coated Tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in coating | IP IP | 5 75 Q.S. | mg mg |
| Rosuvastatin Calcium & Clopidogrel Bisulphate tablets | Each Film coated Tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in coating | IP IP | 10 75 Q.S. | mg mg |
| Terbinafine Hydrochloride & Itraconazole Tablets | Each Film coated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Itraconazole Excipients | IP BP | 250 100 Q.S. | mg mg |
| Rosuvastatin 5 mg & Aspirin 75 tablet | Each Film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Aspirin Excipients Approved colour used | IP IP | 5 75 Q.S. | mg mg |
| Rosuvastatin 10mg & Aspirin 75 mg tablet | Each Film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Aspirin Excipients Approved colour used | IP IP | 10 75 Q.S. | mg mg |
| Rosuvastatin 10 mg & Aspirin 150 tablet | Each Film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Aspirin Excipients Approved colour used | IP IP | 10 150 Q.S. | mg mg |
| Cefixime & Lactic Acid Bacillus Tablets | Each uncoated dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Lactic Acid Bacillus Excipients | IP IP | 200 60 Q.S. | mg Million Spores |
| Pirfenidone 200 mg Tablets | Each Film coated Tablet contains Pirfenidone Excipients Approved colour used | IP | 200 Q.S. | mg |
| Pirfenidone 400 mg Tablets | Each Film coated Tablet contains Pirfenidone Excipients Approved colour used | IP | 400 Q.S. | mg |
| Pantoprazole Sodium & Ondansetron Tablets | Each gastro resistant tablet contains Pantoprazole Sodium eq. to Pantoprazole Ondansetron Hydrochloride ExcipientsApproved colour used | IP IP | 40 4 Q.S. | mg mg |
| Etoricoxib & Paracetamol Tablets | Each film coated tablet contains Etoricoxib Paracetamol Excipients Approved colour used | IP IP | 60 325 Q.S. | mg mg |
| Cefuroxime & Clavulanic Acid Tablets | Each Film coated Tablet contains Cefuroxime Axetil Eq. to Cefuroxime Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients Approved colour used in coating | IP IP | 250 125 Q.S. | mg mg |
| Cefuroxime Axetil 500mg and Clavulanic Acid 125 mg Tablets | Each Film coated Tablet contains Cefuroxime Axetil Eq. to Cefuroxime Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients Approved colour used in coating | IP IP | 500 125 Q.S. | mg mg |
| Cefixime dispersible tablets | Each dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Excipients | IP | 200 Q.S. | mg |
| Ethamsylate Tablets | Each uncoated tablet contains Ethamsylate Excipients Approved colour used | BP | 500 Q.S. | mg |
| Mirtazapine Tablets 7.5 mg | Each film coated tablet contains Mirtazapine Excipients Approved colour used in coating | IP | 7.5 Q.S. | mg |
| Vitamin C, Zinc sulphate & vitamin D3 tablet | Each uncoated chewable tablet contains: Vitamin C Zinc Sulphate Vitamin D3 Excipients Approved Colour Used | 500 22.5 400 Q.S. | mg mg mg |
|
| Calcium Carbonate, vitamin D3 Magnesium Hydroxide , Zinc & copper Tablets | Each film coated tablet contains Calcium Carbonate eq. to Elemental calcium Vitamin D3 Magnesium Hydroxide Eq.to Elemental Magnesium Zinccopper Excipients Approved Colour used | IP IP IP IP IP | 1250 500 400 40 1.8 4 1 Q.S. | mg mg mg mg mg mg mg |
| Ranolazine ER tablets | Each film coated Extended Release tablet contains Ranolazine Excipients Approved colour used in coating | IP | 1000 Q.S. | Calcium Carbonate, vitamin D3 Magnesium Hydroxide , Zinc & copper Tablets |
| Prasugrel Tablets | Each film coated tablet contains Prasugrel Hydrochloride Eq. to Prasugrel Excipients Approved colour used in coating | IP | 10 Q.S. | mg |
| Solifenacin Succinate Tablets 5 mg | Each film coated tablet contains Solifenacin Succinate Excipients Approved colour used in coating | IP | 5 Q.S. | mg |
| Valsartan Tablets 40 mg | Each film coated tablet contains Valsartan Excipients Approved colour used in coating | IP | 40 Q.S. | mg |
| Valsartan Tablets 80 mg | Each film coated tablet contains Valsartan Excipients Approved colour used in coating | IP | 80 Q.S. | mg |
| Valsartan Tablets 160 mg | Each film coated tablet contains Valsartan Excipients Approved colour used in coating | IP | 160 Q.S. | mg |
| Prazosin Hydrochloride Tablets 5 mg | Each uncoated tablet contains Prazosin Hydrochloride ( as sustained release ) Excipients Approved colour used in coating | IP | 5 Q.S. | mg |
| Topiramate Tablets 25 mg | Each film coated tablet contains Topiramate Excipients Approved colour used in coating | IP | 25 Q.S. | mg |
| Topiramate Tablets 50 mg | Each film coated tablet contains Topiramate Excipients Approved colour used in coating | IP | 50 Q.S. | mg |
| Atorvastatin Tablets 80 mg | Each film coated tablet contains Each film coated tablet contains Excipients Approved colour used | IP | 80 Q.S. | mg |
| Glimepiride & Metformin (SR) Tablets | Each film coated tablet contains Glimepiride Metformin HCl Excipients Approved Colour used | IP IP | 1 1000 Q.S. | mg mg |
| Piracetam Tablets 400 mg | Each film coated tablet contains Piracetam Excipients Approved colour used in coating | IP | 400 Q.S. | mg |
| Piracetam Tablets 800 mg | Each film coated tablet contains Each film coated tablet contains Excipients Approved colour used in coating | IP | 800 Q.S. | mg |
| Ursodeoxycholic Acid Tablets IP 450mg | Each uncoated tablets contains Ursodeoxycholic Acid Excipients | IP | 450 Q.S. | mg |
| Ursodeoxycholic Acid tablets IP 600mg | Each uncoated tablets contains Ursodeoxycholic Acid Excipients Each film coated tablet contains | IP | 600 Q.S. | mg |
| Cefprozil Tablets USP 500 mg | Each film coated tablet contains Cefprozil Excipients Approved colour used in coating | USP | 500 Q.S. | mg |
| Cefprozil Tablets USP 250mg | Each film coated tablet contains Cefprozil Excipients Approved colour used | USP | 250 Q.S. | mg |
| Dapagliflozin Tablets 5 mg | Each film coated tablet contains Dapagliflozin Propanediol Monohydrate eq.to Dapagliflozin Excipients Approved colour used | 5 Q.S. | mg | |
| Levocetirizine , Montelukast Sodium & ambroxol Hydrochloride (SR)Tablets | Each film coated tablet contains Levocetirizine Hydrochloride Montelukast Sodium eq. to Montelukast Ambroxol hydrochloride (as sustained release form) Excipients Approved colour used | IP IP IP | 5 10 75 Q.S. | mg mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 400 4 Q.S. | mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 400 8 Q.S. | mg mg |
| Etodolac and paracetamol Tablets | Each film coated tablet contains Etodolac Paracetamol Excipients Approved colour used | IP IP | 400 500 Q.S. | mg mg |
| Ticagrelor Tablets IP 90mg | Each film coated tablet contains Ticagrelor Excipients Approved colour used | IP | 90 Q.S. | mg |
| Trimetazidine modified release Tablets | Each film coated modified release tablet contains Trimetazidine dihydrochloride Excipients Approved colour used | IP | 35 Q.S. | mg |
| Etofylline and Theophylline Tablets | Each film coated tablet contains Etofylline Theophylline (hydrate ) Excipients Approved colour used | IP IP | 115 35 Q.S. | mg mg |
| Etofylline and Theophylline Tablets | Each film coated tablet contains Etofylline Theophylline (hydrate ) Excipients Approved colour used | IP IP | 231 69 Q.S. | mg mg |
| Levocetirizine , & ambroxol Hydrochloride (SR)Tablets | Each film coated tablet contains Levocetirizine Hydrochloride Ambroxol hydrochloride ( as sustained release form) Excipients Approved colour used | IP IP | 5 75 Q.S. | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients Approved Colour used | IP IP | 2 1000 Q.S. | mg mg |
| Betahistine Dihydrochloride Sustained Release Tablets IP 48 mg | Each uncoated sustained release tablet contains: Betahistine Dihydrochloride Excipients | IP | 48 Q.S. | mg |
| Ivermectin Tablets 6 mg | Each filmcoated tablet contains Ivermectin Excipients Colour : approved colour used | IP | 6 Q.S. | mg |
| Esomeprazole Delayed Release Tablets IP 20 mg | Each Delayed Release tablet contains Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Colour : Approved Colour used | IP | 20 Q.S. | mg |
| Metformin (SR) Tablets | Each uncoated sustained release tablet contains Metformin HCl (as sustained release form) Excipients | IP | 1000 Q.S. | mg |
| Telmisartan & Metprolol Succinate (ER) Tablets | Each uncoated tablet contains Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended Release) Excipients Colour :Approved colour used | IP IP | 40 25 Q.S. | mg mg |
| Prazosin sustained release Tablets IP 2 mg | Each filmcoated tablet contains Prazosin Hydrochloride eq. to Prazosin ( as sustained release ) Excipients Approved colour used in coating | IP | 2 Q.S. | mg |
| Bisoprolol fumarate & Hydrochlorothiazide Tablets | Each film coated tablet contains Bisoprolol fumarate Hydrochlorothiazide Excipients Approved Colour Used | IP IP | 5 6.25 Q.S. | mg mg |
| Methylcobalamin, alpha lipoic acid, folic acid, selenium dioxide ,calcium pantothenate Vitamin B1,Vitamin B6, Vitamin E & Beta Carotene tablets | Each film coated tablets contains Methylcobalamin Alpha lipoic acid folic acid selenium dioxide calcium pantothenate Vitamin B1 Vitamin B6 Vitamin E Beta Carotene (10%) Excipients Approved colour used | IP IP IP IP IP IP IP IP USP | 500 50 1.5 163.6 10 10 1.5 25 20.66 Q.S. | mcg mg mg mcg mg mg mg I.U. mg |
| Voglibose & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Metformin Hydrochloride (as sustained release form ) Excipients Excipients | IP IP | 0.2 500 Q.S. | mg mg |
| Voglibose & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Metformin Hydrochloride (as sustained release form ) Excipients Approved colour used | IP IP | 0.3 500 Q.S. | mg mg |
| Paracetamol & Dicyclomine HCl Tablets | Each uncoated tablets contains Paracetamol Dicyclomine HCl Excipients Approved Colour used | IP IP | 325 20 Q.S. | mg mg |
| Ketorolac Tromethamine Tablets IP | Each uncoated tablet contains Ketorolac Tromethamine Excipients Approved colour used | 10 | 10 Q.S. | mg |
| Cinnarizine Tablets IP | Each uncoated tablets contains Cinnarizine Excipients Approved colour used | IP | 25 Q.S. | mg |
| Aceclofenac & Diacerein Tablets | Each Film coated tablets contains Aceclofenac Diacerein Excipients Approved colour used | IP IP | 100 50 Q.S. | mg mg |
| Drotaverin & Mefenamic Tablets | Each film coated tablets contains Drotaverin Hydrochloride Mefenamic Acid Excipients Approved Colour Used | IP IP | 80 250 Q.S. | mg mg |
| Flunarizine Tablets | Each film coated tablets contains Flunarizine Dihydrochloride Excipients Approved Colour Used | BP | 10 Q.S. | mg |
| Mefenamic acid and Tranexamic acid Tablets | Each film coated tablet contains Mefenamic acid Tranexamic acid Excipients Approved colour used | IP | 250 500 Q.S. | mg mg |
| Tranexamic acid Tablets | Each film coated tablet contains Tranexamic acid Excipients Approved colour used | IP | 500 Q.S. | mg |
| Cefixime & Lactic Acid Bacillus Tablet | Each Film coated tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Lactic Acid Bacillus Excipients Approved colour used | IP | 200 60 Q.S. | mg Million Spores |
| Flavoxate Hydrochloride Tablet IP 200 mg | Each film coated tablet Contains Flavoxate HCl Excipients Approved colour used | IP | 200 Q.S. | mg |
| Levofloxacin Tablets IP 500 mg | Each film coated tablets contains Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Approved colour used in coating | IP | 500 Q.S. | mg |
| Levofloxacin Tablets IP 750 mg | Each film coated tablets contains Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Approved colour used in coating | IP | 750 Q.S. | mg |
| Febuxostat Tablets IP 80 mg | Each film coated tablets contains Febuxostat Excipients Approved colour used | IP | 80 Q.S. | mg |
| Ursodeoxycholic Acid tablets IP 300mg | Each film coated tablets contains Ursodeoxycholic Acid Excipients Approved colour used in coating | IP | 300 Q.S. | mg |
| Rosuvastatin Tablets IP 10 mg | Each film coated tablet Contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour: Approved colour used | IP | 10 Q.S. | mg |
| Piroxicam Dispersible Tablets 20 mg | Each uncoated dispersible tablet contains Piroxicam Excipients Approved colour used | IP | 20 Q.S. | mg |
| Doxylamine Succinate, Folic Acid & Pyridoxine HCl Tablets | Each enteric coated Tablet contains Doxylamine Succinate Folic Acid Pyridoxine HCl Excipients Approved colour used | USP IP IP | 10 2.5 10 Q.S. | mg mg mg |
| Doxylamine Succinate, Folic Acid & Pyridoxine HCl Tablets | Each enteric coated Tablet contains Doxylamine Succinate Folic Acid Pyridoxine HCl Excipients Approved colour used | USP IP IP | 20 5 20 Q.S. | mg mg mg |
| Aceclofenac , Paracetamol & Serratiopeptidase Tablets | Each Film coated tablets contains Aceclofenac Paracetamol Serratiopeptidase ( As enteric coated Granules eq. to Enzymatic activity 20,000 units) Excipients Approved colour used | IP IP IP | 100 325 10 Q.S. | mg mg mg |
| Paracetamol , Phenylephrine HCl, Cetirizine Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Cetirizine hydrochloride Excipients Colour: Approved colour used | IP IP IP | 325 10 5 Q.S. | mg mg mg |
| Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablets contains Diclofenac Potassium Paracetamol Serrationpeptidase ( As enteric coated Granules eq. to Enzymatic activity 30,000 units) Excipients Colour: approved colour used in coating | BP IP IP | 50 325 15 Q.S. | mg mg mg |
| Sildenafil Citrate Tablets IP 100 mg | Each film coated tablet contains Sildenafil Citrate Eq. to Sildenafil Excipients Colour : approved colour used | IP | 100 Q.S. | mg |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus tablets | Each film coated tablet contains Amoxycillin Trihydrate Eq. to Amoxycillin Potassium Clavulanate diluted eq. Clavulanic acid Lactic Acid Bacillus In flavoured Syrupy base Approved colour used | IP | 500 125 60 Q.S. | mg mg Million Spores |
| Cefpodoxime & potassium clavulanate Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Potassium clavulanate diluted eq. to clavulanic acid Excipients Approved colour used | IP IP | 200 125 Q.S. | mg mg |
| Cefixime, Potassium Clavulanate tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to Cefixime Anhydrous Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid Excipients Approved colours used | IP IP | 200 125 Q.S. | mg mg |
| Cefixime & Ofloxacin tablets | Each film coated tablet contains Cefixime Trihydrate (Eq. to Anhydrous Cefixime) Ofloxacin Excipients Approved color used | IP IP | 200 200 Q.S. | mg mg |
| Albendazole Tablets IP | Each chewable tablets contains Albendazole Excipients Colour : Approved colour used | IP | 400 Q.S. | mg |
| Albendazole & Ivermectin Tablets | Each chewable tablets contains Albendazole Ivermectin Excipients Colour : approved colour used | IP IP | 400 6 Q.S. | mg mg |
| Domperidone Tablets | Each uncoated tablet contains Domperidone Excipients Each film coated tablets contains | IP | 10 Q.S. | mg |
| Diclofenac Sodium Tablets IP | Each film coated tablets contains Diclofenac Sodium Excipients Approved Colour used | IP | 50 Q.S. | mg |
| Paracetamol Tablets IP 500 mg | Each uncoated tablets contains Paracetamol Paracetamol | IP | 650 Q.S. | mg |
| Cetirizine Dihydrochloride tablets IP | Each uncoated tablet contains Cetirizine Dihydrochloride Excipients | IP | 10 Q.S. | mg |
| Pantoprazole Tablets IP 40 mg | Each enteric coated tablet contains Pantoprazole Sodium Eq. to Pantoprazole Excipients Approved colour used | IP | 40 Q.S. | mg |
| Folic Acid Tablet IP | Each uncoated tablet contains Folic Acid Excipients Each uncoated tablets contains | IP | 5 Q.S. | mg |
| Atenolol Tablets IP | Each uncoated tablets contains Atenolol Excipients | IP | 50 Q.S. | mg |
| Deflazacort Tablets | Each uncoated tablet contains Deflazacort Excipients | IP | 6 Q.S. | mg |
| Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each filmcoated tablets contains Diclofenac Potassium Paracetamol Serrationpeptidase ( As enteric coated Granules eq. to Enzymatic activity 20,000 units) ExcipientsColour: approved colour used in coating | BP IP IP | 50 325 10 Q.S. | mg mg mg |
| DIclofenac & Paracetamol Tablets | Each uncoated tablet contains Diclofenac Potassium Paracetamol excipients | IP IP | 50 325 Q.S. | mg mg |
| Ferrous Ascorbate& Folic Acid Tablet | Each film coated tablet contains Ferrous ascorbate eq. to Elemental iron Folic acid Excipients Approved colour used | IP | 100 1.5 Q.S. | mg mg |
| Etamsylate and Tranexamic acid Tablets | Each film coated tablet contains Etamsylate Tranexamic acid Excipients Approved colour used | BP IP | 250 250 Q.S. | mg mg |
| Amoxycillin& Potassium Clavulanate tablet IP | Each film coated tablet contains Amoxycillin Trihydrate eq.to Amoxycillin Potassium Clavulanate diluted eq. to Clavulanic acid Excipients Approved colour used | IP | 500 125 Q.S. | mg mg |
| Linezolid Tablet IP | Each film coated tablet contains Linezolid Excipients Approved colour used | IP | 600 Q.S. | mg |
| Methylprednisolone Tablets IP 4 mg | Each uncoated tablet contains MethylPrednisolone Excipients | ip | 4 Q.S. | mg |
| Levocetirizine & Montelukast Sodium Tablets | Each uncoated tablets contains Levocetirizine Dihydrochloride Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 5 10 Q.S. | mg mg |
| Cefixime dispersible tablets IP 100 mg | Each dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Excipients | IP | 100 Q.S. | mg |
| Ofloxacin Tablets IP | Each Film coated Tablet contains Ofloxacin Excipients Approved colour used in coating | IP | 200 Q.S. | mg |
| Ofloxacin & Ornidazole Tablets | Each film coated tablet contains Ofloxacin Ornidazole Excipients Approved Colour used | IP IP | 200 500 Q.S. | mg mg |
| Cefpodoxime Proxetil Tablets IP | Each uncoated dispersible Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 200 Q.S. | mg |
| Cefpodoxime Proxetil Tablets IP | Each uncoated dispersible Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 100 Q.S. | mg |
| Cefpodoxime Proxetil Tablets IP | Each uncoated dispersible Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 50 Q.S. | mg |
| Amoxycillin dispersible Tablets IP 250 mg | Each dispersible tablet contains Amoxycillin Trihydrate Eq.to Amoxycillin Excipients Approved Colour used | IP | 250 Q.S. | mg |
| Aceclofenac , Paracetamol & Serratiopeptidase Tablets | Each Film coated tablets contains Aceclofenac Paracetamol Serratiopeptidase ( As enteric coated Granules eq. to Enzymatic activity 30,000 units) Excipients Approved colour used | IP IP IP | 10 325 15 Q.S. | mg mg mg |
| Aceclofenac & Serratiopeptidase Tablets | Each Film coated tablets contains Aceclofenac Serratiopeptidase ( As enteric coated Granules eq. to Enzymatic activity 30,000 units) Excipients Approved colour used | IP IP | 100 15 Q.S. | mg mg |
| Drotaverin & Paracetamol Tablets | Each film coated tablets contains Drotaverin Hydrochloride Paracetamo lExcipients Approved Colour Used | IP IP | 80 325 Q.S. | mg mg |
| Pregabalin & Nortriptyline Tablets | Each film coated tablet contains Pregabalin Nortriptyline HCl Eq. to Nortriptyline Excipients Colour: Approved Colour used | IP IP | 75 10 Q.S. | mg mg |
| Lactic acid Bacillus Tablets | Each uncoated Tablet contains: lactic acid bacillus excipients | 100 Q.S. | Million spores | |
| Calcium Citrate , Magnesium Hydroxide , Zinc Sulphate Monohydrate & Cholecalciferol Tablets | Each uncoated tablet contains Calcium Citrate Magnesium HydroxideEq.to Elemental Magnesium Zinc Sulphate Monohydrate Eq.to Elemental Zinc Cholecalciferol Excipients | USP IP IP IP | 1000 4 4 200 Q.S. | mg mg mg IU |
| Gliclazide & Metformin Tablets | Each uncoated tablet contains Gliclazide Metformin Hydrochloride Excipients | IP IP | 80 500 Q.S. | mg mg |
| Ranitidine Hydrochloride & Domperidone tablets | Each film coated tablet contains Ranitidine Hydrochloride Eq. to Ranitidine Domperidone Excipients Approved Colour Used | IP IP | 150 10 Q.S. | mg mg |
| Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains Trypsin Chymotrypsin (100000 armour units enzymatic activity supplied by a purified concentrate which has specific Trypsin and Chymotrypsin activity in a ratio of apx. 6:1) excipientsApproved colour used | 100000 Q.S. | A.U. |
